Landscape → Metabolic

Diabetes (General)

826 clinical trials

213 active

826 total (since 2015)

Phase 1 Active

244 total

Phase 2 Active

248 total

Phase 3 Active

187 total

Phase 4 Active

225 total

Top Sponsors (Industry)

Sorted by active Active Done Failed

Gan & Lee Pharmaceuticals. 5 0 0

Eli Lilly 2 10 0

EMS 2 0 3

AJU Pharm Co., Ltd. 2 1 0

Sun Pharmaceutical Industries Limited 2 0 0

AstraZeneca 1 6 1

Boryung Pharmaceutical Co., Ltd 1 4 0

Jiangsu HengRui Medicine Co., Ltd. 1 4 0

Pfizer 1 2 1

Shandong Suncadia Medicine Co., Ltd. 1 1 0

Khondrion BV 1 1 0

Getz Pharma 1 1 0

Energenesis Biomedical Co., Ltd. 1 1 0

Hua Medicine Limited 1 1 0

CRISPR Therapeutics AG 1 1 0

NCT07448974 NOT YET RECRUITING

Vitamin D and Type 2 Diabetes - Treat-To-Target

Tufts Medical Center n=100

NCT07284901 RECRUITING

Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Kailera n=1,700

NCT07400653 NOT YET RECRUITING

A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)

Pfizer n=999

NCT07392151 NOT YET RECRUITING

Reversal to Normoglycemia by Treating Prediabetes

Michael Mæng n=158

NCT07391319 RECRUITING

The Prospective, Double-blind, Multicenter, Placebo-controlled, Randomized, Comparative Clinical Trial

JSC NextGen n=144

NCT06451757 RECRUITING

KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases

Khondrion BV n=220

NCT07308184 NOT YET RECRUITING

Bridge Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Patients With T2DM Inadequately Controlled by Diet and Exercise Alone

HK inno.N Corporation n=110

NCT05305794 RECRUITING

Effect of Weekly GLP1 Agonist Treatment in "Double Diabetes"

Centre Hospitalier Universitaire Dijon n=76

NCT07279909 ACTIVE NOT RECRUITING

Phase-III Clinical Studies on Poly Herbal Anti-Diabetic Formulation

Hamdard University n=500

NCT05028140 RECRUITING

Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus

EMS n=480

NCT04602754 RECRUITING

Efficacy and Safety of Berlim 25/20 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia.

EMS n=228

NCT06767735 ACTIVE NOT RECRUITING

A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Insulin-naive Subjects With Type 2 Diabetes Mellitus (T2DM)

Gan & Lee Pharmaceuticals. n=580

NCT06767761 ACTIVE NOT RECRUITING

A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Type 2 Diabetes Mellitus Subjects (T2DM) Treated With Basal + Prandial Insulin

Gan & Lee Pharmaceuticals. n=580

NCT07165223 RECRUITING

A Phase IIIb Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin

Gan & Lee Pharmaceuticals. n=300

NCT06767748 ACTIVE NOT RECRUITING

A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin

Gan & Lee Pharmaceuticals. n=620

NCT07056699 NOT YET RECRUITING

SGLT2i, Pioglitazone, and Ketone Production in T1D

The University of Texas Health Science Center at San Antonio n=24

NCT05887271 RECRUITING

A Randomised, Controlled Trial of a Low-energy Diet for Improving Functional Status in Heart Failure With PRESERVED Ejection Fraction Preserved Ejection Fraction

University of Leicester n=63

NCT05930210 RECRUITING

A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer

Energenesis Biomedical Co., Ltd. n=230

NCT06257966 ACTIVE NOT RECRUITING

A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Dulaglutide in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin

Beijing Dongfang Biotech Co., Ltd. n=600

NCT06217302 RECRUITING

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

Alessandro Doria n=150

NCT05852054 ACTIVE NOT RECRUITING

Supporting Transitions to Primary Care Among Under-resourced, Postpartum Women (STEP-UP)

Northwestern University n=1,500

NCT06909006 NOT YET RECRUITING

Semaglutide Treatment in Type 1 Diabetes

Nordsjaellands Hospital n=122

NCT07073768 ENROLLING BY INVITATION

Comparison Between Efficacy of Trelagliptin and Sitagliptin in Type II Diabetic Patients

Khyber Medical College, Peshawar n=126

NCT06244758 RECRUITING

Finerenone and Renal Oxidative Stress

University of Erlangen-Nürnberg Medical School n=75

NCT06535789 RECRUITING

Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Women With Gestational Diabetes

Jaeb Center for Health Research n=30

NCT06354660 ACTIVE NOT RECRUITING

Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1)

Eli Lilly and Company n=480

NCT06946628 NOT YET RECRUITING

New Triple Therapy in Newly Diagnosed Type 2 Diabetes

Sun Yat-sen University n=296

NCT06286878 RECRUITING

Pleiotropic Effects of Dapagliflozin in Patients With Acute Coronary Syndromes

University of Sao Paulo n=80

NCT06801886 ENROLLING BY INVITATION

Silymarin's Advantage on Graft Effectiveness

University Hospital, Martin n=130

NCT06894784 RECRUITING

A Clinical Trial to Evaluate The Effects of Semaglutide and Empagliflozin Combined to Automated Insulin Delivery on Diabetes Control in Adults Living With Type 1 Diabetes

McGill University Health Centre/Research Institute of the McGill University Health Centre n=36

NCT06847178 NOT YET RECRUITING

Efficacy and Safety of LC-Z300-01 in Chinese With Type 2 Diabetes

Shanghai Changzheng Hospital n=60

NCT06619600 ACTIVE NOT RECRUITING

Effect of Dapagliflozin in Myocardial Fibrosis and Ventricular Function in Patients With a ST-segment Elevation Myocardial Infarction

Hospital Clinic of Barcelona n=54

NCT06820567 NOT YET RECRUITING

Effects Dapagliflozin on Inflammatory Markers Erythropoiesis and Iron Metabolism in Patients with Type 2 Diabetes and CKD

Assiut University n=210

NCT05569772 RECRUITING

Semaglutide for the Treatment of Glucose Intolerance in Women with Prior Gestational Diabetes

Universitaire Ziekenhuizen KU Leuven n=252

NCT06387199 RECRUITING

Alleviating Carbohydrate Counting for Patients with Type-1 Diabetes Using a Closed Loop System with Weekly Subcutaneous Semaglutide

McGill University Health Centre/Research Institute of the McGill University Health Centre n=26

NCT05427084 RECRUITING

Canagliflozin Targeting Vascular Inflammation

Ottawa Heart Institute Research Corporation n=24

NCT05073835 ACTIVE NOT RECRUITING

Semaglutide 2.4 mg in Patients With Poor Weight-loss

University College, London n=70

NCT06619301 RECRUITING

RCT Glargine vs NPH for Treatment of DM in Pregnancy

Loyola University n=160

NCT05769868 RECRUITING

Efficacy of Esmolol in the Identification of Cardiovascular Disorders by Cirrhosis, Diabetes Mellitus and Cardiotoxic Treatments

Consorcio Centro de Investigación Biomédica en Red (CIBER) n=1,000

NCT03982693 RECRUITING

Trial to Assess Chelation Therapy in Critical Limb Ischemia

Mt. Sinai Medical Center, Miami n=50

NCT04547348 RECRUITING

The DENOCHARCOT Trial

Ole Lander Svendsen n=38

NCT06430125 RECRUITING

Nephroprotective Effect of Nicorandil in Type 2 Diabetes Mellitus

Tanta University n=46

NCT05174052 RECRUITING

Dapagliflozin in Patients With Atrial Fibrillation (DAPA-AF)

University of Oklahoma n=28

NCT04181996 RECRUITING

Canadian Study of Arterial Inflammation in Patients With Diabetes and Vascular Events: EvaluatioN of Colchicine

Ottawa Heart Institute Research Corporation n=115

NCT06046417 RECRUITING

A Fully Automated Lyumjev and Pramlintide Delivery System for Adults With Type 1 Diabetes

McGill University Health Centre/Research Institute of the McGill University Health Centre n=30

NCT06346366 ACTIVE NOT RECRUITING

Glucose Control Through a Bihormonal Artificial Pancreas in Patients After Total Pancreatectomy

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) n=40

NCT05505994 ACTIVE NOT RECRUITING

The Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on Metformin

Daewoong Pharmaceutical Co. LTD. n=340

NCT05182970 RECRUITING

Metformin and Prevention of Cardiovascular Events in Patients With Acute Myocardial Infarction and Prediabetes (MIMET)

Karolinska Institutet n=5,160

NCT04581447 RECRUITING

Extending Time Without Diabetes After Bariatric Surgery: a Trial Comparing the Metformin Addition or Not to Standard Care

Assistance Publique - Hôpitaux de Paris n=126

NCT02947503 RECRUITING

Pregnancy Outcomes: Effects of Metformin Study (POEM Study)

Bethesda Diabetes Research Center n=500

NCT04621929 COMPLETED

Phentermine/Topiramate for Uric Acid Stones

University of Florida n=19

NCT06229795 COMPLETED

Effect of Green Tea on Obese Pediatrics With Prediabetes

Ain Shams University n=90

NCT02546401 COMPLETED

Comparison of Insulin's Injection Before or After the Meal in Type 1 Diabetic Patients Treated With Insulin Pump

University Hospital, Brest n=22

NCT03968224 COMPLETED

Effectiveness of Dapagliflozin for Weight Loss

Centro Medico Nacional Siglo XXI IMSS n=160

NCT05260021 COMPLETED

A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both

Eli Lilly and Company n=99

NCT03071692 TERMINATED

Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)

Kowa Research Institute, Inc. n=10,544

NCT02375828 COMPLETED

Glibentek in Patients With Neonatal Diabetes Secondary to Mutations in K+-ATP Channels

Assistance Publique - Hôpitaux de Paris n=10

NCT06340854 COMPLETED

A Research Study to See How Switching From a Daily Basal Insulin to a New Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine in Adults With Type 2 Diabetes

Novo Nordisk A/S n=429

NCT05691712 COMPLETED

A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes

Eli Lilly and Company n=257

NCT05463744 COMPLETED

A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection Therapy

Eli Lilly and Company n=692

NCT05362058 COMPLETED

A Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time

Eli Lilly and Company n=928

NCT06952231 COMPLETED

Effect of Sitagliptin and Empagliflozin in Combination With Metformin on Hs-CRP Levels in Patients With Type 2 Diabetes Mellitus

University of Lahore n=50

NCT05280496 COMPLETED

A Pragmatic Approach to Lower Diabetes Risk After Gestational Diabetes

Tufts Medical Center n=20

NCT06912035 COMPLETED

Efficacy of Diacerein Supplementation on Interleukin-1β, Hs-CRP, TNF-α Levels and Glycemic Control in Uncontrolled Type 2 Diabetes Mellitus Patients at Dr. Mohammad Hoesin General Hospital Palembang

Universitas Sriwijaya n=34

NCT02733185 COMPLETED

Trial to Assess Chelation Therapy 2

Mt. Sinai Medical Center, Miami n=1,000

NCT06107153 COMPLETED

Effect of Short-term Basal Insulin Initiation in Newly Diagnosed Type 2 Diabetes on 1-year Glycemic Control

University of Basrah n=243

NCT04965935 COMPLETED

Efficacy, Mechanisms and Safety of SGLT2 Inhibitors in Kidney Transplant Recipients

University Health Network, Toronto n=52

NCT02980276 COMPLETED

RCT Metformin for Reduction of Gestational Diabetes Mellitus Effects

National University of Ireland, Galway, Ireland n=535

NCT03215069 COMPLETED

Empagliflozin and the Preservation of Beta-cell Function in Women with Recent Gestational Diabetes

Mount Sinai Hospital, Canada n=91

NCT06619015 SUSPENDED

Tailoring Obesity Treatment Trial

Esbjerg Hospital - University Hospital of Southern Denmark n=40

NCT04409795 COMPLETED

Oral Hypoglycemic Therapy for Monogenic Variant Carriers of the Joslin Medalist Study

Joslin Diabetes Center n=3

NCT06770894 COMPLETED

DPP4-Inhibitors and Bone Metabolism in Diabetes

Azienda Policlinico Umberto I n=132

NCT05281562 TERMINATED

Immunonutrition for Diabetic Foot Ulcers

Prisma Health-Midlands n=1

NCT04998032 COMPLETED

A Study of Efficacy and Safety of Supaglutide in Type 2 Diabetes Patients On Metformin Treatment(SUPER-2)

Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. n=620

NCT04233034 COMPLETED

Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes

Jaeb Center for Health Research n=113

NCT03717194 COMPLETED

Effect of Ertugliflozin on Cardiac Function in Diabetes

Soo Lim n=102

NCT04994288 COMPLETED

A Study of Efficacy and Safety of Supaglutide in Type 2 Diabetes Patients(SUPER-1)

Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. n=547

NCT05364190 COMPLETED

Canagliflozin in Patients With Acute Decompansted Heart Failure

October 6 University n=142

NCT03380546 TERMINATED

Acarbose and Prandial Insulin for the Treatment of Gestational Diabetes Mellitus.

Assistance Publique - Hôpitaux de Paris n=341

NCT03324776 COMPLETED

Initiating Mealtime Ultra-Rapid Acting Insulin (Afrezza) in Uncontrolled Type 2 Diabetes Patients

Model Clinical Research LLC n=20

NCT04809220 COMPLETED

A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes

Eli Lilly and Company n=591

NCT03466866 COMPLETED

Reducing Emergency Diabetes Care for Older African Americans

Thomas Jefferson University n=156

NCT06329674 COMPLETED

Efficacy and Safety of AJU-A51 in Type 2 Diabetes Mellitus Patients

AJU Pharm Co., Ltd. n=235

NCT04636411 COMPLETED

Effects of Oral Magnesium Supplementation on Patients With Type 2 Diabetes

Samar Fares, MD n=80

NCT02491528 COMPLETED

A Phase III Study of Insulin Aspart Injection to Evaluate the Efficacy and Safety

Tonghua Dongbao Pharmaceutical Co.,Ltd n=563

NCT03309007 COMPLETED

A Double-Blind, Placebo-Controlled Trial of Anti-Aging, Pro-Autophagy Effects of Metformin in Adults With Prediabetes

University of New Mexico n=25

NCT06127355 COMPLETED

Gestational Treatment With Ursodeoxycholic Acid Compared to Placebo to Reduce Severity of Gestational Diabetes Mellitus Diagnosed at 24-28 Weeks' Gestation

Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia n=113

NCT03784443 WITHDRAWN

Combined Ranibizumab and Iluvien for Diabetic Macular Oedema

Imperial College London

NCT05094401 TERMINATED

Use of an Investigational Digital Therapeutic in Patients With Type 2 Diabetes

Better Therapeutics n=76

NCT03737240 COMPLETED

IDegLira HIGH Trial

Emory University n=145

NCT04970108 WITHDRAWN

Efficacy and Safety of Egito Association in the Treatment of Type II Diabetes Mellitus and Hypertension

EMS

NCT05144360 WITHDRAWN

Efficacy and Safety of Atenas Association in the Treatment of Type II Diabetes Mellitus and Hypertension

EMS

NCT02932475 TERMINATED

Medical Optimization of Management of Type 2 Diabetes Complicating Pregnancy (MOMPOD)

University of North Carolina, Chapel Hill n=831

NCT02947620 COMPLETED

Metformin/Atorvastatin Combination Therapy in Subjects With Type II Diabetes and Dyslipidemia (Phase 3)

Daewoong Pharmaceutical Co. LTD. n=185

NCT04885712 COMPLETED

A Study to Evaluate the Efficacy and Safety of Pioglitazone 15mg or 30mg Add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin

Boryung Pharmaceutical Co., Ltd n=378

NCT03770767 COMPLETED

Insulin Fiasp vs. Insulin Novorapid During Pregnancy and Laction in Women With Pre-existing Diabetes

Rigshospitalet, Denmark n=216

NCT04313088 WITHDRAWN

Investigation of Eluxadoline for Diabetic Diarrhea

Temple University

NCT04762719 COMPLETED

PET Imaging to Delineate Macrophage Activation in Diabetic Gastroparesis

Mayo Clinic n=12

NCT03174522 TERMINATED

The Efficacy and Safety of REX-001 to Treat Ischemic Ulcers in Subjects With CLI Rutherford Category 5 and DM

Ixaka Ltd n=49

NCT03377699 COMPLETED

Research Study Comparing Insulin Degludec to Insulin Detemir, Together With Insulin Aspart, in Pregnant Women With Type 1 Diabetes

Novo Nordisk A/S n=225

NCT03172494 COMPLETED

A Trial Comparing Insulin Degludec/Liraglutide, Insulin Degludec, and Liraglutide in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs)

Novo Nordisk A/S n=720

NCT03344692 COMPLETED

Effect of Alirocumab on Postprandial Hyperlipemia in Patients With Type 2 Diabetes

Nantes University Hospital n=22

NCT03151343 COMPLETED

SGLT-2 Inhibitor and Myocardial Perfusion, Function and Metabolism in T2 DM Patients at High Cardiovascular Risk

Caroline M Kistorp n=92

NCT03766750 WITHDRAWN

Efficacy and Safety of Lima Association in the Control of Type II Diabetes Mellitus.

EMS

NCT02849080 COMPLETED

Efficacy and Safety of Oral Semaglutide Using a Flexible Dose Adjustment Based on Clinical Evaluation Versus Sitagliptin in Subjects With Type 2 Diabetes Mellitus.

Novo Nordisk A/S n=504

NCT02863328 COMPLETED

Efficacy and Safety of Oral Semaglutide Versus Empagliflozin in Subjects With Type 2 Diabetes Mellitus

Novo Nordisk A/S n=822

NCT02692716 COMPLETED

A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes

Novo Nordisk A/S n=3,183

NCT02906930 COMPLETED

Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Diet and Exercise Only

Novo Nordisk A/S n=703

NCT02863419 COMPLETED

Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes Mellitus

Novo Nordisk A/S n=711

NCT02607865 COMPLETED

Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes

Novo Nordisk A/S n=1,864

NCT03979352 COMPLETED

Effect of SGLT2i in Conjunction With the Artificial Pancreas on Improving the Glycemia in T1DM in the Outpatient Setting

Samuel Lunenfeld Research Institute, Mount Sinai Hospital n=28

NCT04800172 COMPLETED

The Possible Effects of Roflumilast on Obesity Related Disorders

Tanta University n=66

NCT05290506 COMPLETED

Linagliptin Response to OGTT in Prediabetes and Type 2 Diabetes Mellitus

National University of Malaysia n=50

NCT03078478 COMPLETED

A Trial Comparing the Efficacy and Safety of Insulin Degludec and Insulin Glargine 300 Units/mL in Subjects With Type 2 Diabetes Mellitus Inadequately Treated With Basal Insulin With or Without Oral Antidiabetic Drugs

Novo Nordisk A/S n=1,609

NCT03268005 COMPLETED

Research Study Comparing a New Medicine "Fast-acting Insulin Aspart" to Another Already Available Medicine "NovoRapid"/"NovoLog" in People With Type 2 Diabetes

Novo Nordisk A/S n=1,264

NCT03420781 TERMINATED

A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03

Allergan n=467

NCT04170998 COMPLETED

Efficacy and Safety of Evogliptin When Added to Ongoing Metformin and Dapagliflozin Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control

Dong-A ST Co., Ltd. n=283

NCT03383146 TERMINATED

A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04

Allergan n=450

NCT05038046 COMPLETED

Combined Western and Traditional Chinese Medicine Daycare for DM Nephropathy Patients

China Medical University Hospital n=25

NCT04674332 COMPLETED

Long Acting Insulin Versus Multiple Dose Regimen for Control of Gestational Diabetes Mellitus

Ain Shams University n=148

NCT03739125 COMPLETED

Efficacy and Safety of CKD-501 Added to D150 Plus D745 10mg Therapy in Patients With Type 2 Diabetes

Chong Kun Dang Pharmaceutical n=226

NCT03426345 TERMINATED

Study to Evaluate the Safety and Efficacy of Relamorelin in Participants With Diabetic Gastroparesis Study 02

Allergan n=311

NCT03285308 TERMINATED

A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis 01

Allergan n=336

NCT03259789 COMPLETED

Safety and Efficacy of Bexagliflozin Compared to Placebo as Add-on Therapy to Metformin in Type 2 Diabetes Subjects

Theracos n=351

NCT03086330 COMPLETED

Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to SGLT-2i in Subjects With Type 2 Diabetes Mellitus

Novo Nordisk A/S n=302

NCT03480022 COMPLETED

Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS

Woman's n=88

NCT04371978 TERMINATED

Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19

Rabin Medical Center n=64

NCT03026426 COMPLETED

Effectiveness of a mHealth Intervention for the Treatment of Depression in People With Diabetes or Hypertension in Peru

Universidad Peruana Cayetano Heredia n=432

NCT03111238 TERMINATED

The Efficacy and Safety of REX-001 to Treat Ischemic Rest Pain in Subjects With CLI Rutherford Category 4 and DM

Ixaka Ltd n=3

NCT02607306 COMPLETED

A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Japanese Subjects With Type 2 Diabetes Mellitus.

Novo Nordisk A/S n=819

NCT02911948 COMPLETED

A Double-blinded Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec Both in Combination With Metformin in Japanese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal or Pre-mix/Combination Insulin Therapy and Oral Anti-diabetic Drugs

Novo Nordisk A/S n=210

NCT03015220 COMPLETED

Safety and Efficacy of Oral Semaglutide Versus Dulaglutide Both in Combination With One OAD (Oral Antidiabetic Drug) in Japanese Subjects With Type 2 Diabetes

Novo Nordisk A/S n=458

NCT03061214 COMPLETED

Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin in Subjects With Type 2 Diabetes (SUSTAIN - CHINA MRCT)

Novo Nordisk A/S n=868

NCT03018028 COMPLETED

Dose-response, Safety and Efficacy of Oral Semaglutide Versus Placebo and Versus Liraglutide, All as Monotherapy in Japanese Subjects With Type 2 Diabetes

Novo Nordisk A/S n=243

NCT01002209 WITHDRAWN

Postoperative Hyperbaric Oxygen Treatments to Reduce Complications in Diabetic Patients Undergoing Vascular Surgery

Karolinska Institutet

NCT02964247 COMPLETED

LIRA-ADD2SGLT2i - Liraglutide Versus Placebo as add-on to SGLT2 Inhibitors.

Novo Nordisk A/S n=303

NCT02868177 COMPLETED

Effect of Totum-63, Active Ingredient of Valedia, on Glucose and Lipid Homeostasis on Subjects With Prediabetes

Valbiotis n=66

NCT02592421 COMPLETED

SGLT2 Inhibition and Stimulation of Endogenous Glucose Production: Protocol 2

The University of Texas Health Science Center at San Antonio n=30

NCT02773368 COMPLETED

A Clinical Trial Comparing Glycaemic Control and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine (IGlar) as add-on Therapy to SGLT2i in Subjects With Type 2 Diabetes Mellitus

Novo Nordisk A/S n=420

NCT03651531 TERMINATED

Comparison of Insulin Alone to Insulin With Metformin to Treat Gestational Diabetes Mellitus

Women and Infants Hospital of Rhode Island n=1

NCT04079413 COMPLETED

Efficacy and Safety of GP40071 Compared to NovoRapid® Penfill® in Type 1 Diabetes Mellitus Patients

Geropharm n=264

NCT02419612 COMPLETED

A 52-week International, Multicenter Trial With a Long -Term Extension to Evaluate Saxagliptin With Dapagliflozin in Combination With Metformin Compared to Glimepiride in Combination With Metformin in Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone

AstraZeneca n=444

NCT04361552 WITHDRAWN

Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)

Emory University

NCT03430856 COMPLETED

Comparison of Insulin Tregopil (IN-105) With Insulin Aspart in Type 2 Diabetes Mellitus Patients

Biocon Limited n=143

NCT04069234 WITHDRAWN

Study in Diabetes Mellitus Patients Without Prior Myocardial Infarction or Stroke Undergoing Elective Percutaneous Coronary Intervention.

Region Skane

NCT03175120 COMPLETED

A Trial Comparing Insulin Degludec/Liraglutide and Insulin Degludec in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Therapy and Metformin With or Without One Other Oral Antidiabetic Drug (OAD)

Novo Nordisk A/S n=453

NCT03116009 TERMINATED

Randomization of Early Diabetes Screening Among Obese Pregnant Women.

University of Illinois at Chicago n=600

NCT03021187 COMPLETED

Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Insulin

Novo Nordisk A/S n=731

NCT03173963 WITHDRAWN

Empaglifozin in Early Diabetic Kidney Disease

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NCT02827708 COMPLETED

Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment

Novo Nordisk A/S n=324

NCT03136484 COMPLETED

Efficacy and Safety of Semaglutide Versus Canagliflozin as add-on to Metformin in Subjects With Type 2 Diabetes

Novo Nordisk A/S n=788

NCT02984644 COMPLETED

Paradoxical Stimulation of Hepatic Glucose Production With Dapagliflozin

The University of Texas Health Science Center at San Antonio n=30

NCT02501161 COMPLETED

A 104 Week Clinical Trial Comparing Long Term Glycaemic Control of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine Therapy in Subjects With Type 2 Diabetes Mellitus

Novo Nordisk A/S n=1,012

NCT02825251 COMPLETED

Efficacy and Safety of Continuous Subcutaneous Insulin Infusion of Faster-acting Insulin Aspart Compared to NovoRapid® in Adults With Type 1 Diabetes

Novo Nordisk A/S n=472

NCT02906917 COMPLETED

A 38 Week Trial Comparing Effect and Safety of Insulin Degludec/Insulin Aspart vs. Insulin Glargine Plus Insulin Aspart in Subjects With Type 2 Diabetes Treated With Basal Insulin With or Without Oral Antidiabetic Treatment in Need of Treatment Intensification

Novo Nordisk A/S n=532

NCT03191396 COMPLETED

Research Study Comparing a New Medicine Semaglutide to Liraglutide in People With Type 2 Diabetes

Novo Nordisk A/S n=577

NCT02648204 COMPLETED

Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.

Novo Nordisk A/S n=1,201

NCT03421379 COMPLETED

A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus

Eli Lilly and Company n=75

NCT03433677 COMPLETED

A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes

Eli Lilly and Company n=49

NCT02402933 COMPLETED

Clinical Usability of Nasal Glucagon in Treatment of Hypoglycemia in Children and Adolescents

Eli Lilly and Company n=26

NCT03565666 COMPLETED

The Insulin-Only Bionic Pancreas Bridging Study

Massachusetts General Hospital n=36

NCT02752113 COMPLETED

Effects of Empagliflozin + Linagliptin vs Metformin + Insulin Glargine on Renal and Vascular Changes in Type 2 Diabetes

Institut für Pharmakologie und Präventive Medizin n=101

NCT04023344 COMPLETED

Efficacy and Safety of Insulin Lispro Biphasic 25 Compared to Humalog® Mix 25 in Type 2 Diabetes Mellitus Patients

Geropharm n=210

NCT04022993 COMPLETED

Efficacy and Safety of Insulin RinGlar® Compared to Lantus® SoloStar® in Type 1 Diabetes Mellitus Patients

Geropharm n=180

NCT03289338 COMPLETED

Zoledronic Acid or Methylprednisolone for Active Charcot's Neuroarthropathy of Foot in Patients With Diabetes Mellitus

Post Graduate Institute of Medical Education and Research, Chandigarh n=36

NCT02735837 COMPLETED

The Effect of Topical Doxycycline Gel on HbA1c in Patients With Type 2 Diabetes Mellitus(DM) ®

Amirhossein Farahmand n=24

NCT02500706 COMPLETED

Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Adults With Type 1 Diabetes

Novo Nordisk A/S n=1,108

NCT02338193 COMPLETED

Dapagliflozin and Metformin,Alone and in Combination, in Overweight/Obese Prior GDM Women

Woman's n=69

NCT02670915 COMPLETED

Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 Diabetes

Novo Nordisk A/S n=834

NCT02762578 COMPLETED

Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Subjects With Type 2 Diabetes

Novo Nordisk A/S n=543

NCT03851055 COMPLETED

Zinc Supplementation in Patients With β-Thalassemia Major Complicated With Diabetes Mellitus

Ain Shams University n=80

NCT03841591 COMPLETED

Maternal Weight Gain in Gestational Diabetes Controlled by Metformin Versus Insulin

Ain Shams University n=124

NCT03745300 COMPLETED

Comparative Evaluation Of 1.2% Atorvastatin and 1.2% Simvastatin Gel Local Drug Delivery And Redelivery In Chronic Periodontitis Subjects With Diabetes Mellitus: A Randomized Controlled Clinical Trial.

Government Dental College and Research Institute, Bangalore n=120

NCT02082756 WITHDRAWN

Effects of Berberine Hydrochloride and Bifidobacterium in Prediabetes Prevention and Treatment

Xijing Hospital

NCT02846662 COMPLETED

Effectiveness of a Mobile Technology Intervention for the Treatment of Depression

University of Sao Paulo General Hospital n=880

NCT02586129 COMPLETED

Clinical Trial of YH14755 in Subjects With Dyslipidemia and Type II Diabetes

Yuhan Corporation n=249

NCT02648217 COMPLETED

Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart Twice Daily and Biphasic Insulin Aspart Twice Daily in Subjects With Type 2 Diabetes Mellitus Before, During and After Ramadan

Novo Nordisk A/S n=263

NCT02505334 COMPLETED

A Trial Comparing the Efficacy and Safety of Liraglutide 1.8 mg/Day to Liraglutide 0.9 mg/Day in Japanese Subjects With Type 2 Diabetes Mellitus.

Novo Nordisk A/S n=635

NCT02145988 TERMINATED

DLBS1033 Treatment in Diabetic With Peripheral Arterial Disease

Dexa Medica Group n=11

NCT02478762 TERMINATED

Glycemic Objectives of Women With Gestational Diabetes Mellitus

Université de Sherbrooke n=5

NCT02420262 COMPLETED

A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Basal-bolus Therapy in Subjects With Type 2 Diabetes Mellitus

Novo Nordisk A/S n=506

NCT03320694 COMPLETED

Comparison of Metformin and Insulin for Management of Gestational Diabetes Mellitus

Services Institute of Medical Sciences, Pakistan n=278

NCT02484209 WITHDRAWN

DiaFrail: A Short Duration Study in Older People ( DIAFRAIL Study)

Diabetes Frail Ltd

NCT02622672 COMPLETED

Water-soluble Ubiquinol Supplementation on Blood Glucose, Lipids, Oxidative Stress, and Inflammation in Diabetes

Yeh n=50

NCT02662400 COMPLETED

Assessment of Insulin Sensitivity and β Cell Function by Clamps Studies

Post Graduate Institute of Medical Education and Research, Chandigarh n=7

NCT02985099 COMPLETED

1.2% Rosuvastatin Subgingivally Delivered In Chronic Periodontitis With Type 2 Diabetes Mellitus

Government Dental College and Research Institute, Bangalore n=80

NCT02568501 COMPLETED

Behavioral Economic Incentives to Improve Glycemic Control Among Adolescents and Young Adults

University of Pennsylvania n=90

NCT07313787 NOT YET RECRUITING

Effects of Meal Macronutrients on Postprandial Lipids

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NCT06851858 ACTIVE NOT RECRUITING

Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor Agonist

AstraZeneca

NCT06575426 RECRUITING

A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus

Otsuka Pharmaceutical Factory, Inc.

NCT07186660 RECRUITING

Evaluation of a Novel Insulin Sensitizer in People With Type 1 Diabetes

University of Virginia

NCT06368817 RECRUITING

A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma

Children's Oncology Group

NCT05759468 RECRUITING

NAD Augmentation in Diabetes Kidney Disease

Brigham and Women's Hospital

NCT06897202 ACTIVE NOT RECRUITING

A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM

Metsera, a wholly owned subsidiary of Pfizer

NCT07282743 RECRUITING

Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus

Sun Pharmaceutical Industries Limited

NCT07167693 RECRUITING

Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes

David K Carroll

NCT04666636 RECRUITING

Mechanisms for Activation of Beige Adipose Tissue in Humans

Philip Kern

NCT07189234 RECRUITING

Long Term Impact of Time-Restricted Eating on Parameters of Cardiometabolic Health

University of California, San Diego

NCT06972407 NOT YET RECRUITING

The Effect of rs7903146 Genotype on Islet GLP-1 Production in Humans

Mayo Clinic

NCT07369284 NOT YET RECRUITING

Melatonin for Glycemic Control in Gestational Diabetes Mellitus

Obstetrics & Gynecology Hospital of Fudan University

NCT04341571 ACTIVE NOT RECRUITING

Effect of Probiotics Versus Metformin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Prediabetes.

University of Guadalajara

NCT07319286 ENROLLING BY INVITATION

Role of Glucagon-like Peptide-1 Receptor Agonists in Menstrual Irregularities in Adolescent Females With Type 1 Diabetes Mellitus

Ain Shams University

NCT06688331 RECRUITING

Treatment of Presymptomatic (Stage 1) Type 1 Diabetes Pediatric Patients With Treg Cell Preparations and Anti-CD20 Antibody

PolTREG S.A.

NCT07340320 NOT YET RECRUITING

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

Corxel Pharmaceuticals

NCT06948825 RECRUITING

Effectiveness Study of a Lifestyle Intervention Versus Metformin in Mothers With Recent Gestational Diabetes

George Washington University

NCT06036004 RECRUITING

Oxytocin Substitution Therapy in Patients With Central Diabetes Insipidus

University Hospital, Basel, Switzerland

NCT07300982 NOT YET RECRUITING

Studies of Insulin and Glucagon Action in the Liver

Duke University

NCT02846571 RECRUITING

Pancreatic Islet Transplantation Into the Anterior Chamber of the Eye

Midhat H. Abdulreda

NCT07029009 RECRUITING

Liraglutide Treatment in Patients With Maturity-onset Diabetes of the Young (MODY)

Mansa

NCT07286747 NOT YET RECRUITING

Efficacy and Safety of Oral Controlled-release Nicotinic Acid (CIR-NA) for the Remission of Prediabetes. (CONCEPT)

University Hospital Schleswig-Holstein

NCT06967558 RECRUITING

The Role of Islet GLP-1 in the Pathogenesis of Prediabetes

Mayo Clinic

NCT04542148 ACTIVE NOT RECRUITING

Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational Diabetes

University of Alabama at Birmingham

NCT02081326 ACTIVE NOT RECRUITING

Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes

Massachusetts General Hospital

NCT05180591 RECRUITING

Repeat BCG Vaccinations For The Treatment Of Pediatric Type 1 Diabetes

Massachusetts General Hospital

NCT05866536 RECRUITING

Repeat BCG Vaccinations for the Treatment of New Onset Type 1 Diabetes in Children Age 8-<18 Years

Massachusetts General Hospital

NCT06305286 RECRUITING

Safety, Tolerability, and Efficacy of Immunomodulation With A Monoclonal Antibody Against CD40L in Combination With Transplanted Islet Cells in Adults With Brittle Type 1 Diabetes Mellitus (T1D)

University of Chicago

NCT05500586 ACTIVE NOT RECRUITING

The Effects of Glucagon on Hepatic Metabolism

Adrian Vella

NCT04742751 ACTIVE NOT RECRUITING

An Open-Label Pilot Intervention Trial to Prevent Diabetes in Prediabetic Adult Survivors of Childhood Cancer

St. Jude Children's Research Hospital

NCT04141761 ACTIVE NOT RECRUITING

Probiotics in Newly Diagnosed T1D

Medical College of Wisconsin

NCT06808516 RECRUITING

Effects of Intranasal Oxytocin on Sexual Well-Being in Patients With Arginine Vasopressin Deficiency and Healthy Controls

University Hospital, Basel, Switzerland

NCT03782636 ACTIVE NOT RECRUITING

Interleukin-2 Therapy of Autoimmunity in Diabetes (ITAD)

University of Oxford

NCT06813274 NOT YET RECRUITING

Multicenter RCT of Eye-Brain Imaging in Diabetes Neurovascular Coupling

Hejiang Ye

NCT06964087 ACTIVE NOT RECRUITING

Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus

Op-T LLC

NCT05199077 NOT YET RECRUITING

A Study of GM-XANTHO in Pressure Ulcer Patients

Xantho Biotechnology Co., LTD

NCT04547439 RECRUITING

Sleep, Diabetic Retinopathy and Melatonin

University of Illinois at Chicago

NCT04451837 ACTIVE NOT RECRUITING

Semaglutide and Dapagliflozin in Diabetic Patients With Different Pathophysiology

Region Skane

NCT04055428 RECRUITING

NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals

University of Alabama at Birmingham

NCT07025980 NOT YET RECRUITING

Effect of Sinbiotic With Multispecies Probiotics on Liver Parameters Liver Enzymes, Ultrasound, Elastography and Adipokines in Same Cases) in Patients With Metabolic Associated Steatotic Liver Disease.

Eva Cubric

NCT07020377 ACTIVE NOT RECRUITING

Dapagliflozin in Nonalcoholic Fatty Liver Disease (NAFLD) and Type 2 Diabetes Mellitus Patients (T2DM).

Amira Bisher,PhD

NCT06729996 RECRUITING

Pioglitazone Versus Empagliflozin for Chronic Pancreatitis/Recurrent Acute Pancreatitis Associated Diabetes Mellitus

Mayo Clinic

NCT06794723 NOT YET RECRUITING

A Probiotic Based Intervention in Pregnancies Complicated by GDM

Queen's University

NCT05499702 RECRUITING

The Effects of Glucagon on Hepatic Metabolism in People With Type 2 Diabetes After Caloric Restriction

Adrian Vella

NCT05301413 RECRUITING

Social Determinants and a Diabetes Prevention Program Tailored for African Americans

University of Missouri, Kansas City

NCT06676774 RECRUITING

Effect of Intranasal Oxytocin on Emotion Recognition and Acute Psycho-Social Stress-induced Cortisol Increase in Patients With Central Diabetes Insipidus and Healthy Controls

University Hospital, Basel, Switzerland

NCT06976658 NOT YET RECRUITING

Glucokinase Activator in Monogenic Diabetes

Chinese University of Hong Kong

NCT06337708 RECRUITING

Smart Walk: A Culturally Tailored Smartphone-Delivered Physical Activity Intervention for African American Women

Arizona State University

NCT04984226 RECRUITING

Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD

University of California, Davis

NCT03389100 ENROLLING BY INVITATION

Tau PET Imaging in the Northern Manhattan Study of Metabolism and Mind.

Columbia University

NCT06411210 RECRUITING

Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment

Yale University

NCT04335656 ACTIVE NOT RECRUITING

Reducing Innate Inflammation in New Onset Type 1 Diabetes

Medical College of Wisconsin

NCT04731272 RECRUITING

GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance

University of Pennsylvania

NCT03865290 RECRUITING

Effects of Ondansetron on Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus and Dyspepsia

Mayo Clinic

NCT06938334 NOT YET RECRUITING

A First-in-human Clinical Trial Using a Gene Therapy With Patient's Own Stem Cells to Treat Early Type 1 Diabetes

Altheia Science

NCT04722354 ACTIVE NOT RECRUITING

Abscisic Acid Effects on Glucose Homeostasis and Insulin Sensitivity

AdventHealth Translational Research Institute

NCT06030544 ACTIVE NOT RECRUITING

Oleanolic Acid as Therapeutic Adjuvant for Type 2 Diabetes Mellitus (OLTRAD STUDY)

Spanish National Research Council

NCT06860087 NOT YET RECRUITING

Impact of Chromium Supplementation on Glucido-lipidic Metabolism, Oxidative Stress and Inflammatory State in Patients with Gestational Diabetes

University of Kasdi Merbah

NCT06762314 RECRUITING

Efficacy and Safety of Empagliflozin or Semaglutide in Overweight/Obese Patients With Type 1 Diabetes

Mostafa Bahaa

NCT06727721 RECRUITING

Safety and Efficacy of OCN19-overexpressed Human Umbilical Cord-derived Mesenchymal Stem Cells in the Treatment of Refractory Type 2 Diabetes Mellitus

Lu jin ，MD

NCT06731231 ACTIVE NOT RECRUITING

SGLT2i in Diabetic Patients with Renal Transplantation

Ain Shams University

NCT05061030 RECRUITING

Mesenchymal Stromal Cells to Treat Type 1 Diabetes in Children and Adolescents

Uppsala University Hospital

NCT06703788 RECRUITING

Integrated Traditional Chinese Medicine Day Care Program for Metabolic Syndrome

Chang Gung Memorial Hospital

NCT05810311 NOT YET RECRUITING

The Effect of Roxadustat on Renal Oxygenation in Diabetes Nephropathy

Region Stockholm

NCT04589325 RECRUITING

Ixekizumab Diabetes Intervention Trial (I-DIT)

Göteborg University

NCT04511468 ACTIVE NOT RECRUITING

Zinc, Chromium, Vitamin C, and Copper Combination Supplement for Prediabetes Progression

Indonesia University

NCT06575478 RECRUITING

Evaluation of Fuling Yunhua Granules and Dihuang Baoyuan Granules in Drug Naive Type 2 Diabetes Patients

Beijing Supreme Life Pharmaceutical Technology Co., Ltd.

NCT05844644 RECRUITING

The Effects of the GOLO for Life® Plan With Release Supplement on Glycemic Control and Weight in Overweight and Obese Adults With Prediabetes or Type 2 Diabetes

Golo

NCT06448052 ACTIVE NOT RECRUITING

Umbilical Cord Mesenchymal Stem Cell for Aging-related Low-grade Inflammation

Nguyen Ton Ngoc Huynh

NCT05565248 RECRUITING

An Open-Label, FIH Study Evaluating the Safety, Tolerability, and Efficacy of VCTX211 Combination Product in Subjects With T1D

CRISPR Therapeutics AG

NCT06413238 NOT YET RECRUITING

Rationale and Design of Diabetes Management With Curcumin and Saffron (DMCS): a Randomised, Three Blind -Blind, Placebo-controlled Study

Fateme Moshirenia

NCT05124457 RECRUITING

DETERMINE: Detemir vs NPH

University of California, Los Angeles

NCT04684602 RECRUITING

Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions

Thomas Advanced Medical LLC

NCT03325322 SUSPENDED

Inflammation and Stem Cells in Diabetic and Chronic Kidney Disease

Mayo Clinic

NCT05190744 COMPLETED

Probenecid (PB) to Treat Hereditary Nephrogenic Diabetes Insipidus (NDI), ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium Administration

Mayo Clinic

NCT02586831 WITHDRAWN

Diabetes Islet Preservation Immune Treatment

Camillo Ricordi and Jay Skyler

NCT03620773 COMPLETED

Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes

University of Colorado, Denver

NCT03999853 COMPLETED

Butyrate Adjuvant Therapy for Type 1 Diabetes

Mayo Clinic

NCT05115188 COMPLETED

DIAgnosing GDM usiNg Oral Sugar InStead

Sunnybrook Health Sciences Centre

NCT06526494 WITHDRAWN

Metformin and Vascular Function in Prediabetes

Diana Jalal

NCT04628481 TERMINATED

A Study of Oral Ladarixin in Recent Onset Type 1 Diabetes and a Low Residual β-cell Function

Dompé Farmaceutici S.p.A

NCT05207995 COMPLETED

The Treatment of Patients With Type 1 Diabetes Mellitus With Autologous Tolerogenic Dendritic Cells

Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus

NCT06651515 WITHDRAWN

A Study of the Safety and Efficacy of Pancreatic Endocrine Cell Clusters Implanted Into the Omentum of Type 1 Diabetes Patients With Severe Hypoglycemia

Seraxis

NCT03406897 COMPLETED

Pilot Study of OMEGA-3 and Vitamin D in High-Dose in Type I Diabetic Patients

Rodolfo Alejandro

NCT06849843 COMPLETED

A Study of 3mg Once Every Two Weeks Administration of Efsubaglutide Alfa Injection in Type 2 Diabetes Patients.

Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.

NCT04776239 COMPLETED

Allogeneic Mesenchymal Human Stem Cell Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects With Symptomatic Ischemic Heart Disease. (ACESO-IHD)

Joshua M Hare

NCT06011798 COMPLETED

Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE)

Unity Biotechnology, Inc.

NCT04083456 COMPLETED

Dysvascular Amputation Self-Management of Health

University of Colorado, Denver

NCT04455633 COMPLETED

Efficacy, Safety, and PK of LX9211 in Participants With Diabetic Peripheral Neuropathic Pain

Lexicon Pharmaceuticals

NCT04262479 COMPLETED

Injections of Glutamic Acid Decarboxylase (GAD) for LADA Type of Diabetes

Norwegian University of Science and Technology

NCT03566511 TERMINATED

Use of Functional MRI to Assess Functional Hypothalamic Activation in Response to Diazoxide

Meredith Hawkins

NCT03973827 COMPLETED

Wharton´s Jelly Derived Mesenchymal Stromal Cell Repeated Treatment of Adult Patients Diagnosed with Type I Diabetes

NextCell Pharma Ab

NCT04227769 TERMINATED

IL-1-receptor Antagonist During Cephalic Phase of Insulin Secretion in Health and Type 2 Diabetes

University Hospital, Basel, Switzerland

NCT05854251 COMPLETED

Hyperinsulinemia in Prediabetes Mediated by Interleukin-1β

University Hospital, Basel, Switzerland

NCT05160272 COMPLETED

Effects of GABAA Receptor Modulation by AP-325 on Insulin Secretion in Patients with Type 2 Diabetes

The Deutsche Diabetes Forschungsgesellschaft e.V.

NCT04259047 COMPLETED

Health Beliefs, Glycemic Control, and Preventing Cognitive Decline in African Americans with Diabetes and Mild Cognitive Impairment: a Randomized Clinical Trial

Thomas Jefferson University

NCT05829239 WITHDRAWN

ADI-PEG20, Obesity and Prediabetes

Washington University School of Medicine

NCT02302079 COMPLETED

A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)

Astellas Pharma Europe B.V.

NCT05803772 COMPLETED

A Study to Evaluate Efficacy and Safety of Distal Jejunal-release Dextrose Beads Formulation in Subjects With a Pathological Oral Glucose Tolerance Test

Aphaia Pharma US LLC

NCT05579977 TERMINATED

Trial to Learn About the Study Medicine (PF-07081532) and Rybelsus in People With Type 2 Diabetes and Separately PF-07081532 in People With Obesity

Pfizer

NCT05990205 COMPLETED

Effect of the SCL16A11 Risk Haplotype on Treatments to Prevent Type 2 Diabetes

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

NCT03243058 WITHDRAWN

Low-dose IL-2 in Established T1D - The "PROREG" Study

Jay S. Skyler

NCT05073237 WITHDRAWN

Effects of Novel Estrogens on Glucose and Lipids in Postmenopausal Prediabetic Women Veterans

VA Office of Research and Development

NCT02915263 TERMINATED

The Efficacy Of Intravenous Immunoglobulin Therapy In Treatment Induced Neuropathy Of Diabetes

Beth Israel Deaconess Medical Center

NCT05762471 COMPLETED

Phase 1b/2a Study of GSBR-1290 in Adult Overweight or Obese Healthy Subjects and Subjects With Type 2 Diabetes Mellitus

Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics

NCT02814838 COMPLETED

A Phase 2, Multicentre, Randomized, Double-blind, Placebo-controlled Study in Patients With New-onset Type 1 Diabetes

Dompé Farmaceutici S.p.A

NCT03428945 TERMINATED

Hydroxychloroquine in Individuals At-risk for Type 1 Diabetes Mellitus

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NCT03826472 COMPLETED

Almond Butter and Fasting Glucose

Penn State University

NCT04074317 COMPLETED

Phase 2, Randomized, Open-Label, Crossover, PD/PK Study of a Novel Pram-Insulin Co-Formulation in Adults With T1D

Xeris Pharmaceuticals

NCT02829268 COMPLETED

A Clinical Trial of Dantrolene Sodium in Pediatric and Adult Patients With Wolfram Syndrome

Washington University School of Medicine

NCT02653300 COMPLETED

A Pilot Study to Assess the Safety of Oral Insulin in Patients With Nonalcolholic Steatohepatitis (NASH)

Oramed, Ltd.

NCT04604548 COMPLETED

The KHENEREXT Study

Khondrion BV

NCT04907214 COMPLETED

SGLT2 Inhibitor Effects on Inflammation and Heart Disease in Obesity Pilot

Vanderbilt University Medical Center

NCT05035368 WITHDRAWN

Ladarixin as Adjunctive Therapy to Improve Insulin Sensitivity and Glucometabolic Outcomes in Type 1 Diabetes

Dompé Farmaceutici S.p.A

NCT04527107 COMPLETED

A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema

Oxurion

NCT05219812 COMPLETED

A Study to Learn How Safe BAY2395840 is and How Well it Works in Participants Who Have Diabetic Nerve Pain

Bayer

NCT04437485 COMPLETED

eIMPACT-DM Pilot Trial: Depression Treatment to Reduce Diabetes Risk

Indiana University

NCT04786340 COMPLETED

A 12-Week Study of Topical Pirenzepine or Placebo in Type 2 Diabetic Patients (T2DM) With Painful Peripheral Neuropathy

WinSanTor, Inc

NCT06051565 COMPLETED

Cardiovascular Contrast-enhanced Magnetic Resonance Imaging Using Polysaccharide Superparamagnetic Iron Oxide Injection in Diabetic Patients

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

NCT05063734 TERMINATED

A Study to Evaluate THR-687 Treatment for Diabetic Macular Oedema.

Oxurion

NCT03654651 COMPLETED

Peanuts and Glycemic Control

Penn State University

NCT03117998 COMPLETED

Multiple Dose Study to Evaluate the Efficacy, Safety and Pharmacodynamics of REMD-477 in Subjects With Type 1 Diabetes Mellitus

REMD Biotherapeutics, Inc.

NCT03406585 COMPLETED

Wharton´s Jelly Derived Mesenchymal Stromal Cell Treatment of Adult Patients Diagnosed With Type I Diabetes

NextCell Pharma Ab

NCT03060577 COMPLETED

An Extension Trial of Inclisiran in Participants With Cardiovascular Disease and High Cholesterol

Novartis Pharmaceuticals

NCT03486223 COMPLETED

Soluble Epoxide Hydrolase Inhibition and Insulin Resistance

Vanderbilt University Medical Center

NCT04830969 COMPLETED

Impact of Periodontal Therapy on Patients With Diabetes

State University of New York at Buffalo

NCT02730962 TERMINATED

Interventional Bioremediation of Microbiota in Metabolic Syndrome

University of Minnesota

NCT03751007 COMPLETED

A Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Combination With Teplizumab in Participants With Recent-onset Diagnosed Type 1 Diabetes (T1D)

Precigen Actobio T1D, LLC

NCT03596177 COMPLETED

A Study to Evaluate the Effect of MEDI0382 on Energy Balance in Overweight and Obese Participants With Type 2 Diabetes Mellitus

MedImmune LLC

NCT03345004 COMPLETED

Diamyd Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 Diabetes

Diamyd Medical AB

NCT04617275 COMPLETED

A 12-WEEK TITRATE STUDY TO EVALUATE SAFETY, TOLERABILITY AND PHARMACODYNAMICS OF PF-06882961 IN ADULTS WITH TYPE 2 DIABETES MELLITUS AND IN NON-DIABETIC ADULTS WITH OBESITY

Pfizer

NCT05631444 COMPLETED

Bone Marrow Mononuclear Cells vs Mesenchymal Stem Cells in Diabetic Patients With Chronic Limb Ischemia

Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle

NCT04387448 TERMINATED

A Study of TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease

Goldfinch Bio, Inc.

NCT03714594 COMPLETED

Effects of Dapagliflozin+Saxagliptin in Addition to Metformin v/s Saxagliptin or Dapagliflozin in Patients With DM2.

University of Pisa

NCT03961256 COMPLETED

Assess the Efficacy and Safety of Exenatide SR for the Prevention of Diabetes After Kidney Transplantation

Mayo Clinic

NCT05240274 COMPLETED

The POWERED Study: Prophylaxis With Metformin to Prevent PTDM

Barts & The London NHS Trust

NCT04123067 TERMINATED

Pioglitazone Treatment for Hyperglycemic Acute Ischemic Stroke

Milton S. Hershey Medical Center

NCT04209075 COMPLETED

Prebiotics and Metformin Improve Gut and Hormones in Type 2 Diabetes in Youth (MIGHTY-fiber)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NCT04956263 COMPLETED

A Comparison of Postprandial Glucose After a MMTT, and the Metabolic Effects of Insulin Withdrawal in a Crossover Study in Subjects With Type 1 Diabetes

Youngene Therapeutics Inc., Ltd.

NCT05439473 COMPLETED

Evaluation of the Efficacy and Safety of Curalin as Add-On Therapy in Adults With Type 2 Diabetes Mellitus

CuraLife

NCT03443635 COMPLETED

Cooking for Health Optimization With Patients

Tulane University

NCT03462069 COMPLETED

Comparison of Pharmacodynamic Effects of Sotagliflozin and Empagliflozin in T2DM Patients With Mild to Moderate Hypertension

Sanofi

NCT03618420 COMPLETED

Copeptin in Adolescent Participants With Type 1 Diabetes and Early Renal Hemodynamic Function

University of Colorado, Denver

NCT03283566 COMPLETED

Hydroxychloroquine and Metabolic Outcomes in Patients Undergoing TPAIT

The Cleveland Clinic

NCT04071977 COMPLETED

Combined Antioxidant Therapy on Oxidative Stress in Aqueous and Vitreous Humor of Diabetic Retinopathy Patients

University of Guadalajara

NCT03878277 COMPLETED

Evaluation of Coffee Therapy for Improvement of Renal Oxygenation

University of Colorado, Denver

NCT02801448 COMPLETED

Clinical Trial With Broccoli Sprout Extract to Patients With Type 2 Diabetes

Anders Rosengren, MD PhD

NCT03135535 COMPLETED

Micro-mobile Foot Compression and Diabetic Foot

Baylor College of Medicine

NCT02532088 WITHDRAWN

Modulating Effects of Oil Palm Phenolics in Subjects With Pre-diabetes

Universiti Sains Malaysia

NCT03178773 COMPLETED

TExT-MED + FANS Full Trial

University of Southern California

NCT03304626 COMPLETED

Budesonide for Liver Transplant Immune Suppression

University of Cincinnati

NCT03668470 COMPLETED

Dulaglutide and Insulin MicrosecretiON in Type 1 Diabetes

Hospices Civils de Lyon

NCT04530617 TERMINATED

Camostat and Artemisia Annua vs Placebo in COVID-19 Outpatients

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

NCT04028960 TERMINATED

IN Insulin in Type 1 Diabetes (T1D) Hypoglycemia Unawareness: Safety Only Phase

HealthPartners Institute

NCT03339336 TERMINATED

Efficacy and Safety Study of BIIB074 in Participants With Small Fiber Neuropathy

Biogen

NCT02443155 COMPLETED

A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function

Novo Nordisk A/S

NCT04838145 COMPLETED

The Diabetes Virus Detection and Intervention Trial

Oslo University Hospital

NCT04102202 WITHDRAWN

BOL-DP-o-05 as an Add-On Treatment of Subjects With Newly Diagnosed Type 1 Diabetes Mellitus

Breath of Life International Pharma Ltd

NCT04159766 COMPLETED

A Study With NLY01 in Subjects With Type 2 Diabetes

Neuraly, Inc.

NCT02691247 COMPLETED

Safety and Efficacy of CLBS03 in Adolescents With Recent Onset Type 1 Diabetes (The Sanford Project T-Rex Study)

Lisata Therapeutics, Inc.

NCT03268941 COMPLETED

A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)

Millennium Pharmaceuticals, Inc.

NCT02672436 COMPLETED

ENERGI-F703 for Diabetic Foot Ulcers Phase II Study

Energenesis Biomedical Co., Ltd.

NCT03760640 COMPLETED

A Study of LY900014 in a Medtronic Pump

Eli Lilly and Company

NCT03544242 TERMINATED

Nitrite Infusion in Islet Cell Transplantation

University of Alabama at Birmingham

NCT02416193 TERMINATED

Can Vitamin D3 Improve Cognitive Function in Individuals With Type 2 Diabetes? (THINK-D)

Loyola University

NCT04372355 COMPLETED

Effect of WF10 (TCDO) on HbA1c Values in Diabetic Foot Ulcer Patients

Srinakharinwirot University

NCT03179423 COMPLETED

Clinical Trial Assessing the GNbAC1 in Patients With Onset of Type 1 Diabetes Within 4 Years

GeNeuro Australia PTY Ltd

NCT03729479 COMPLETED

The MHERO Study (Michigan's Hypertension, Diabetes, and Obesity Education Research Online)

University of Michigan

NCT03655535 COMPLETED

Multicenter Study to Evaluate the Effect of BTI320 on Glycemic Control in Type 2 Diabetes

Boston Therapeutics

NCT02967653 COMPLETED

Atorvastatin for the Treatment of Lithium-Induced Nephrogenic Diabetes Insipidus

Lady Davis Institute

NCT03334175 COMPLETED

Walnuts to Achieve Lasting NUTrition to Prevent Diabetes

University of California, San Francisco

NCT03396484 WITHDRAWN

Methyldopa for Reduction of DQ8 Antigen Presentation in At-Risk Subjects for Type 1 Diabetes

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NCT03227484 COMPLETED

Effect of Empagliflozin Versus Placebo on Brain Insulin Sensitivity in Patients With Prediabetes

University Hospital Tuebingen

NCT02412852 COMPLETED

A Phase 2a Study to Assess Safety & Pharmacokinetics of Sustained Release Sodium Nitrite in Patients With Diabetic Pain

TheraVasc Inc.

NCT03550378 COMPLETED

A Study to Look at the Effect MEDI0382 Has on Blood Sugar in People With Type 2 Diabetes and Kidney Problems and Also to Check That MEDI0382 is Well Tolerated

MedImmune LLC

NCT03531905 COMPLETED

Bempedoic Acid + Ezetimibe Fixed-Dose Combination (FDC) Study in Patients With Type 2 Diabetes and Elevated LDL-C

Esperion Therapeutics, Inc.

NCT03352674 COMPLETED

Immunogenicity Study of Insulin Glargine Ezelin vs Lantus in Type 2 Diabetes Mellitus Patients

Indonesia University

NCT04299763 COMPLETED

Oat Beta-glucan as a Supplement in Chilean Type 2 Diabetics

Centro de Estudios en Alimentación y Nutrición, Chile

NCT04289948 WITHDRAWN

Assessing the Efficacy of Anti-staphylococcal Phages in the Management of Infected Foot Ulcers in Diabetes

University Hospitals of Derby and Burton NHS Foundation Trust

NCT02819011 COMPLETED

OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO

Bijan Najafi, PhD

NCT02790957 TERMINATED

Plerixafor in Diabetic Wound Healing

Gian Paolo Fadini

NCT02457897 COMPLETED

Thyroid Hormone to Induce Non-Insulin Mediated Glucose Disposal in People With Insulin Receptor Mutations

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NCT02496000 COMPLETED

Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus

Oramed, Ltd.

NCT03037593 WITHDRAWN

High Dose Cholecalciferol to Reduce the Incidence of Gestational Diabetes in High Risk Pregnant Women

University of Minnesota

NCT03667300 COMPLETED

Effect of Evogliptin on Albuminuria in Patients With Type 2 Diabetes and Renal Insufficiency

Samsung Medical Center

NCT03152552 TERMINATED

A Dose Finding Study to Assess the Effect of LIK066 Compared to Placebo or Empagliflozin in Patients With Type 2 Diabetes Mellitus and Heart Failure

Novartis Pharmaceuticals

NCT02942056 WITHDRAWN

The Effect of Cinnamon Cassia on Diabetes Control and Cardiometabolic Risk Factors in Adults With Type 2 Diabetes Mellitus

Oregon Health and Science University

NCT03499223 COMPLETED

A Study to Evaluate THR-317 and Ranibizumab Combination Treatment for Diabetic Macular Oedema (DME)

Oxurion

NCT02461589 COMPLETED

Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 Diabetes

Novo Nordisk A/S

NCT02357420 COMPLETED

Safety and Efficacy of Relamorelin Administered to Participants With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis

Allergan

NCT03591458 TERMINATED

Amitriptyline in Treating Hypoglycemia

University of Utah

NCT02597127 COMPLETED

Trial to Evaluate the Effect of ALN-PCSSC Treatment on Low Density Lipoprotein Cholesterol (LDL-C)

The Medicines Company

NCT03943979 COMPLETED

Pilot Study of an Intervention Involving Cognitive Training and tDCS in Morbidly Obese Subjects

Parc de Salut Mar

NCT03113110 COMPLETED

Empagliflozin in Post-Transplantation Diabetes Mellitus

Medical University of Vienna

NCT02118714 COMPLETED

Atrasentan Spermatogenesis and Testicular Function

AbbVie

NCT03076528 COMPLETED

An Innovative Virtually Supervised Exercise for Dialysis Patients

Baylor College of Medicine

NCT02470039 COMPLETED

Trial to Compare NNC0123-0000-0338 in a Tablet Formulation and Insulin Glargine in Subjects With Type 2 Diabetes Currently Treated With Oral Antidiabetic Therapy

Novo Nordisk A/S

NCT03132181 COMPLETED

Empagliflozin as a Modulator of Systemic Vascular Resistance and Cardiac Output in Patients With Type 2 Diabetes

RWTH Aachen University

NCT02496390 COMPLETED

Transplantation of Microbes for Treatment of Metabolic Syndrome & NAFLD

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

NCT02727608 COMPLETED

Complement Inhibitor Eculizumab in Clinical Islet Transplantation

Uppsala University

NCT02492763 TERMINATED

A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004)

Merck Sharp & Dohme LLC

NCT02739217 COMPLETED

Safety and Tolerability of PBI-4050 and Its Effects on the Biomarkers in Subjects With Alström Syndrome

Liminal BioSciences Ltd.

NCT03156361 COMPLETED

21 Day Comparison of Continuous Insulin Infusion Using HDV Insulin to Standard Insulin in Type 1 Diabetes Mellitus

Diasome Pharmaceuticals

NCT02784275 COMPLETED

A Study to Evaluate the Efficacy and Safety of Cyclo-Z in Patients With Obese Type 2 Diabetes

NovMetaPharma Co., Ltd.

NCT02455011 COMPLETED

Dose Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of REMD-477 in Subjects With Type 2 Diabetes Mellitus

REMD Biotherapeutics, Inc.

NCT01881958 WITHDRAWN

The Safety and Efficacy of Administrating DiaPep277® Vaccination in Type 1 Diabetes Patients.

Hadassah Medical Organization

NCT03193944 COMPLETED

Vitamin D Supplementation on Metabolic Syndrome Indicators Among Older Adults, Alborz Province, Iran

Alborz Medical University

NCT03024944 WITHDRAWN

TAU PET Imaging in Northern Manhattan Study of Metabolism and Mind

Columbia University

NCT02324010 COMPLETED

Effects of Sitagliptin on Gastric Emptying, Glycaemia and Blood Pressure in Type 2 Diabetes

Royal Adelaide Hospital

NCT02541734 COMPLETED

Effect of Gelofusine on GLP1-receptor Imaging

Radboud University Medical Center

NCT02358668 COMPLETED

BTI320 (SUGARDOWN®) on Post-Prandial Hyperglycaemia in Subjects With Pre-Diabetes

Chinese University of Hong Kong

NCT02916251 COMPLETED

ZP4207(Dasiglucagon) Administered to T1D Patients to Assess the PK and PD Compared to Marketed Glucagon

Zealand Pharma

NCT02274740 TERMINATED

Effect of Lixisenatide on Postprandial Lipid Profile in Obese Type 2 Diabetic Patients

Sanofi

NCT02673866 WITHDRAWN

Study to Evaluate the Efficacy and Safety of DS-1971a for the Treatment of Diabetic Peripheral Neuropathic Pain (DPNP)

Daiichi Sankyo

NCT02491814 COMPLETED

The Effect of Dairy and Non-dairy Alternatives on Satiety and Post-meal Glycemia in Healthy Young Adults

University of Toronto

NCT02607007 COMPLETED

The Effect of Dairy and Non-dairy Breakfasts on Satiety and Post-meal Glycemia in Healthy Older Adults

University of Toronto

NCT02446028 SUSPENDED

A Study Evaluating Safety and Efficacy of BIOD 531 Compared to Humalog® Mix 75/25 in Subjects With Type 2 Diabetes

Biodel

NCT06982859 RECRUITING

A Study to Evaluate the Effect of Retatrutide on Insulin Secretion and Insulin Sensitivity in Adult Participants With Type 2 Diabetes Mellitus

Eli Lilly and Company

NCT06623396 RECRUITING

A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer

Memorial Sloan Kettering Cancer Center

NCT07385547 NOT YET RECRUITING

Study to Evaluate if Exposure to Drug is Impacted in Participants With Renal Insufficiency

Sun Pharmaceutical Industries Limited

NCT07224334 RECRUITING

Role of Alpha-to-beta Cell Communication to Adapt Insulin Secretion to Insulin Resistance.

David D'Alessio, M.D.

NCT06911372 RECRUITING

The Impact of Gestational Diabetes Mellitus on Cerebral Blood Flow and Cerebrovascular Function After Pregnancy

Anna Stanhewicz, PhD

NCT07193147 ACTIVE NOT RECRUITING

Pharmacokinetic and Safety Study of GZR4 Injection in Subjects With Hepatic Impairment

Gan & Lee Pharmaceuticals.

NCT06446531 RECRUITING

Prevention of Progression of Prediabetes, Obesity and CV Risk

The University of Texas Health Science Center at San Antonio

NCT06731218 RECRUITING

Phase I Clinical Study to Evaluate the Safety and Efficacy of RGB-5088 in Patients With Type 1 Diabetes Mellitus

Hangzhou Reprogenix Bioscience, Inc

NCT06829563 RECRUITING

Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RZ-629 in Healthy Subjects and T2D

Rezubio Pharmaceuticals Co., Ltd.

NCT07083388 RECRUITING

A Study to Evaluate the Pharmacokinetics and Safety Between "BR3006" and Co-administration of "BR3006A", "BR3006B", and "BR3006C" in Healthy Adult Volunteers (Fasting)

Boryung Pharmaceutical Co., Ltd

NCT05071898 RECRUITING

Pharmacogenetics of Response to GLP1R Agonists

University of Maryland, Baltimore

NCT07044765 NOT YET RECRUITING

A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults: Fed State Study

AJU Pharm Co., Ltd.

NCT07034781 NOT YET RECRUITING

A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults

AJU Pharm Co., Ltd.

NCT04934228 RECRUITING

Mitigating the Pro-inflammatory Phenotype of Obesity

University of Kansas Medical Center

NCT06105931 RECRUITING

Physiologic Markers of Cardiometabolic Risk in People With Type 1 Diabetes

Yale University

NCT06901726 NOT YET RECRUITING

Open, Randomized Crossover Study on PK, PD, Biopotency, and Bioavailability of Insulin Capsules in Healthy Chinese Males

Shanghai Jiao Tong University School of Medicine

NCT05610865 RECRUITING

Efficacy of Adipose Tissue Derived Stem Cells for the Treatment of Diabetic Foot Ulcers

University of the Punjab

NCT06753994 RECRUITING

Continuous Ketone Monitoring in People With Type 1 Diabetes Using SGLT2 Inhibitors

McGill University

NCT06727838 NOT YET RECRUITING

Study on Drug Interaction of Metformin Tablets and HRS-7535 Tablets in Healthy Human

Shandong Suncadia Medicine Co., Ltd.

NCT06648876 NOT YET RECRUITING

PK and PD of YG1699 in CKD Patients With Diabetes

RenJi Hospital

NCT05634174 ACTIVE NOT RECRUITING

ADRB3 Signaling Pathway in Human Adipose Tissue

University of California, San Diego

NCT06375031 RECRUITING

Comparison of HR011408 and NovoRapid® in Subjects With Diabetics

Jiangsu HengRui Medicine Co., Ltd.

NCT05176210 RECRUITING

Safety, Pharmacokinetics, and Food Effect of PS1 in Subjects

Pharmasaga Co. Ltd.

NCT06258473 RECRUITING

Addressing Gaps in the Hypertension and Diabetes Care Continuum in Rural Bangladesh: The Dinajpur Study

BRAC University

NCT07436585 COMPLETED

CGM-Guided Acarbose for Painful Diabetic Neuropathy

Shifa International Hospital

NCT06961643 COMPLETED

Investigation of Pharmacokinetics and Safety of HRS-7535 in Subjects With Hepatic Impairment and Normal Hepatic Function

Shandong Suncadia Medicine Co., Ltd.

NCT06547541 TERMINATED

Pilot - Resistance Exercise for Inpatient Treatment in T2D

Rigshospitalet, Denmark

NCT06648031 COMPLETED

Comparison of the Safety, Efficacy and Pharmacokinetics of DehydraTECH -CBD and DehydraTECH-GLP1 Agonists Alone or in Combination, in Overweight or Obese, Pre- and Type 2 Diabetic Participants

Lexaria Bioscience Corp.

NCT02724566 COMPLETED

Effect of Apelin on Insulin Sensitivity in Type 2 Diabetic Volunteers

University Hospital, Toulouse

NCT06828731 COMPLETED

Evaluation of Empagliflozin vs Standard Care in Veterans With Prediabetes

Charles George VA Medical Center

NCT04838405 COMPLETED

A Study of CT-388 in Otherwise Healthy Overweight and Obese Adults and Patients With Type 2 Diabetes Mellitus

Carmot Therapeutics, Inc.

NCT05670379 COMPLETED

Assessment of Safety, Tolerability and Drug Levels of Exenatide Implant

Vivani Medical, Inc

NCT02107976 COMPLETED

Famine From Feast: Linking Vitamin C, Red Blood Cell Fragility, and Diabetes

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NCT05349591 WITHDRAWN

cePolyTregs in Islet Transplantation

University of Alberta

NCT07020949 COMPLETED

Multiple Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of THDBH120 in Chinese Patients With T2DM

Tonghua Dongbao Pharmaceutical Co.,Ltd

NCT04869761 COMPLETED

Stem Cell Therapy for Chronic Kidney Disease

LaTonya J. Hickson

NCT06997731 COMPLETED

Clinical Efficacy of Local Delivery of Minocycline and Hyaluronan Gel to Treat Periodontitis in Diabetic Patients

Kafrelsheikh University

NCT06823856 COMPLETED

Pharmacokinetics and Bioequivalence Study of Empagliflozin+Metformin Hydrochloride 12.5 mg/1000 mg Film-coated Tablets (Gedeon Richter Plc., Hungary) Versus Synjardy 12.5 mg/1000 mg Film-coated Tablets (Boehringer Ingelheim International GmbH, Germany)

Gedeon Richter Plc.

NCT04279613 COMPLETED

A Multiple Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0361-0041

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NCT05362968 COMPLETED

Strawberries and Risk of Diabetes in Adults

University of Nevada, Las Vegas

NCT05330208 TERMINATED

Single Ascending Dose and Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-1816 in Healthy Subjects

Beijing Suncadia Pharmaceuticals Co., Ltd

NCT06766500 COMPLETED

Pharmacokinetics and Bioequivalence Study of Empagliflozin+Metformin Hydrochloride 5 mg/850 mg Film-coated Tablets (Gedeon Richter Plc., Hungary) Versus Synjardy® 5 mg/850 mg Film-coated Tablets (Boehringer Ingelheim International GmbH, Germany)

Gedeon Richter Plc.

NCT06792968 COMPLETED

Pharmacokinetics and Bioequivalence Study of Empagliflozin+Metformin Hydrochloride 5 mg/1000 mg Film-coated Tablets (Gedeon Richter Plc., Hungary) Versus Synjardy 5 mg/1000 mg Film-coated Tablets (Boehringer Ingelheim International GmbH, Germany)

Gedeon Richter Plc.

NCT05003908 TERMINATED

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Diabetes

The Foundation for Orthopaedics and Regenerative Medicine

NCT06498284 COMPLETED

Evaluate HM-002-1005 in Subjects With Type 2 Diabetes Mellitus

Hua Medicine Limited

NCT06059404 COMPLETED

Tailoring OT and RD Services for Home-delivered Meal Clients

Ohio State University

NCT04973111 COMPLETED

A Study to Assess CT-868 and the Relationship Between Insulin Secretory Response and Ambient Blood Glucose

Carmot Therapeutics, Inc.

NCT03673111 COMPLETED

Study of the Gut Hormone Analogue Y14 in Adult Subjects

Imperial College London

NCT06846567 COMPLETED

Phase I Study of BM2216 ER vs. Melogabalin Besilate: Safety, PK, and Food Effect in Healthy Adults

Zhejiang Anglikang Pharmaceutical Co., Ltd.

NCT04167553 COMPLETED

Study for Multiple Doses of HM15136(Efpegerglucagon) in Obese or Overweight Subjects With Comorbidities

Hanmi Pharmaceutical Company Limited

NCT05526430 COMPLETED

Study of Harmine in Healthy Subjects

James Murrough

NCT06652971 COMPLETED

A Clinical Trial to Evaluate the Food Effect of CKD-379

Chong Kun Dang Pharmaceutical

NCT03444064 COMPLETED

PolyTreg Immunotherapy in Islet Transplantation

University of Alberta

NCT06547502 COMPLETED

Pharmacokinetics and Safety Profile of a Single Dose GZR4 in Subjects with Renal Impairment

Gan and Lee Pharmaceuticals, USA

NCT05831644 COMPLETED

A Trial to Evaluate the Effect of C21 on Endothelial Dysfunction in Subjects With Type 2 Diabetes

Vicore Pharma AB

NCT02987738 COMPLETED

Pilot Study to Explore the Efficacy of DAPAglifozin as add-on to Closed-loop Control in Patients With Type 1 Diabetes

Kinderkrankenhaus auf der Bult

NCT02624804 COMPLETED

A Pilot Study of the Therapeutic Potential of Stem Cell Educator Therapy in Type 1 Diabetes

Hackensack Meridian Health

NCT06553248 COMPLETED

A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GZR4 in Subjects With Type 2 Diabetes

Gan and Lee Pharmaceuticals, USA

NCT06552182 COMPLETED

Phase 1 Study in Diabetes Mellitus(Fasting)

Huons Co., Ltd.

NCT06551740 COMPLETED

Phase 1 Study in Diabetes Mellitus(Fed)

Huons Co., Ltd.

NCT06548815 COMPLETED

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single-dose GZR4

Gan and Lee Pharmaceuticals, USA

NCT06386328 COMPLETED

A Clinical Trial to Evaluate the Food Effect of CKD-378

Chong Kun Dang Pharmaceutical

NCT06432673 COMPLETED

The Attractive 2 Trial - Pharmacokinetics of ATR-258 Oral Capsule vs. Oral Solution Formulations in Healthy Volunteers

Atrogi AB

NCT06450262 COMPLETED

Bioequivalence Study to Compare Empagliflozin/ Metformin HCl 12.5mg/1000mg Film-coated Tablets

Humanis Saglık Anonim Sirketi

NCT06289933 COMPLETED

A Study to Compare the Pharmacokinetics and the Safety Between a Fixed-dose Combination Administration of "BR3005" and Co-administration of "BR3005-1" and "BR3005-2" Under Fed Conditions in Healthy Adult Volunteers

Boryung Pharmaceutical Co., Ltd

NCT05816577 COMPLETED

Safety and Viability of an E. Coli Nissle Colibactin Knockout in Healthy Volunteers

Max Nieuwdorp

NCT04812262 COMPLETED

A Phase 1 Study of DD01 in Overweight/Obese Subjects With T2DM and NAFLD

Neuraly, Inc.

NCT05409027 COMPLETED

A Study to Assess 11 Beta-hydroxysteroid Dehydrogenase Type 1 Inhibition in Adipose Tissue by SPI-62

Sparrow Pharmaceuticals

NCT05741437 COMPLETED

A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-378

Chong Kun Dang Pharmaceutical

NCT05928637 COMPLETED

A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of D745, D759, and D150

Chong Kun Dang Pharmaceutical

NCT05737576 COMPLETED

The Pharmacokinetics and Pharmacodynamics Between HR011408 and NovoRapid® in Healthy Subject

Jiangsu HengRui Medicine Co., Ltd.

NCT04305587 COMPLETED

Multiple Escalating Oral Doses Study of PF-07081532 in Adult Participants With Type 2 Diabetes Mellitus

Pfizer

NCT03704818 COMPLETED

Dapagliflozin Effects on Hypoglycemia

University of California, San Diego

NCT06180109 COMPLETED

Bioequivalence Study of Empagliflozin 25 mg Film Coated Tablets of Humanis, Turkey and Jardiance (Empagliflozin) 25 mg Film-coated Tablets of Boehringer Ingelheim International GmbH, Germany in Normal, Healthy, Adult, Human Subjects Under Fasting Condition

Humanis Saglık Anonim Sirketi

NCT05881213 COMPLETED

Clinical Trial to Investigate the Pharmacokinetics and Safety After Oral Administration of CKD-378 and Co-administration of D745, D150, D029 in Healthy Adults

Chong Kun Dang Pharmaceutical

NCT05437848 COMPLETED

Chinese Multiple Dose Escalation (MDE) High Dose Study

AstraZeneca

NCT05951946 COMPLETED

A Study to Evaluate Drug-drug Interactions and Safety Between "BR3006-1", "BR3006-2", and "BR3006-3" in Healthy Volunteers

Boryung Pharmaceutical Co., Ltd

NCT04919954 COMPLETED

Tebipenem (SPR994) Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo Microdialysis

Hartford Hospital

NCT06083116 COMPLETED

Drug-Drug Interaction Study Between Henagliflozin Proline and Hydrochlorothiazide

Jiangsu HengRui Medicine Co., Ltd.

NCT04508751 COMPLETED

PED NEONAT 20-000599 Fetal Body Composition

University of California, Los Angeles

NCT05887895 COMPLETED

To Compare the Pharmacokinetics and Pharmacodynamics of HR20014, INS068 and INS062 After Single Subcutaneous Injection in Healthy Subjects

Jiangsu HengRui Medicine Co., Ltd.

NCT05210530 COMPLETED

An Open-Label, FIH Study Evaluating the Safety and Tolerability of VCTX210A Combination Product in Subjects With T1D

CRISPR Therapeutics AG

NCT04855292 COMPLETED

A Study of TG103 Injection in Overweight/Obese Subjects Without Diabetes

CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

NCT05908513 WITHDRAWN

NAC Treatment and Outcomes in Patients With Advanced Atherosclerosis and DM

University of Missouri-Columbia

NCT05336071 COMPLETED

The Relative Bioavailability of INS068 Injection With Two Different Formulations in Healthy Subjects

Jiangsu HengRui Medicine Co., Ltd.

NCT05719155 COMPLETED

Pharmacokinetics and Safety/Tolerability of CKD-379

Chong Kun Dang Pharmaceutical

NCT05544214 COMPLETED

Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD 371 in Healthy Subjects

Chong Kun Dang Pharmaceutical

NCT04068272 COMPLETED

Safety of Bosentan in Type II Diabetic Patients

Retinset SL

NCT05089617 COMPLETED

To Evaluate the Safety, Tolerability, and Pharmacokinetics of YG1699（Antidiabetic） in Healthy Chinese Sbjects

Youngene Therapeutics Inc., Ltd.

NCT04540016 COMPLETED

Mass Balance and Biotransformation of [14C]HSK7653 in Human

Sichuan Haisco Pharmaceutical Group Co., Ltd

NCT05274880 COMPLETED

Study to Evaluate the Food Effect on Pharmacokinetics Profile and Safety of CKD-393

Chong Kun Dang Pharmaceutical

NCT05452525 COMPLETED

Pharmacokinetics and Safety/Tolerability Profile of CKD-379

Chong Kun Dang Pharmaceutical

NCT03681691 COMPLETED

The Interaction Between Diabetes and Estradiol on Human Brain Metabolism in Postmenopausal Women

Wake Forest University Health Sciences

NCT05347576 COMPLETED

A Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393(2) in Healthy Volunteers Under Fed Conditions

Chong Kun Dang Pharmaceutical

NCT02002130 COMPLETED

The Use of Glutamic Acid Decarboxylase (GAD) and Gamma-Amino Butyric Acid (GABA) in the Treatment of Type I Diabetes

University of Alabama at Birmingham

NCT02910518 COMPLETED

A Study to Demonstrate Bioequivalence Between Insulin Glulisine U300 and Insulin Glulisine U100 After a Single Subcutaneous Dose Using the Euglycemic Clamp Technique, in Patients With Type 1 Diabetes Mellitus

Sanofi

NCT03414723 COMPLETED

A Drug-Drug Interaction Study Between Sotagliflozin and Ramipril

Sanofi

NCT03174548 COMPLETED

A Study to Evaluate the Effect of Food on the Pharmacokinetics of Sotagliflozin and to Explore the Relative Bioavailability in Healthy Subjects

Sanofi

NCT03909451 COMPLETED

Sotagliflozin Multiple-dose Study in Healthy Chinese Subjects

Sanofi

NCT03070678 COMPLETED

Interaction Study to Evaluate the Effects of Mefenamic Acid on the Pharmacokinetics and Pharmacodynamics of Sotagliflozin in Healthy Male and Female Subjects

Sanofi

NCT03063580 COMPLETED

Effect of Rifampicin on the Pharmacokinetics and Pharmacodynamics of Sotagliflozin

Sanofi

NCT04880291 COMPLETED

First-In-Human Study of GFB-024 in Healthy Overweight and Obese Participants, and Participants With Type 2 Diabetes

Goldfinch Bio, Inc.

NCT03073070 COMPLETED

RBC Lifespan Measurement in Diabetic Children

Guohua An

NCT05066516 COMPLETED

The Pharmacokinetics, Safety and Tolerability of IN-C009 in Healthy Subjects

Korea University Anam Hospital

NCT03795389 COMPLETED

Study to Assess PK, Safety and Tolerability in Patients With DM and CKD

DiaMedica Therapeutics Inc

NCT02964104 COMPLETED

A Trial Investigating the Safety, Tolerability, Pharmacokinetics (the Exposure of the Trial Drug in the Body) and Pharmacodynamics (the Effect of the Investigated Drug on the Body) of Insulin 287 in Subjects With Type 2 Diabetes

Novo Nordisk A/S

NCT04144374 COMPLETED

Omadacycline Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo Microdialysis

Hartford Hospital

NCT03859934 COMPLETED

Metabolic Effects of Melatonin Treatment

University of Aarhus

NCT04625595 COMPLETED

Multiple Ascending Dose (MAD) Study of IMT-002 in HLA-DQ8-positive Type 1 Diabetes

Immunomolecular Therapeutics, Inc.

NCT04768673 COMPLETED

A Study to Investigate the PK and Safety of CKD-393

Chong Kun Dang Pharmaceutical

NCT03197324 COMPLETED

Bexagliflozin Drug/Drug Interaction Study With Digoxin

Theracos

NCT02956044 COMPLETED

Interaction of Bexagliflozin With Metformin, Glimepiride and Sitagliptin

Theracos

NCT04810676 COMPLETED

A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-383.

Chong Kun Dang Pharmaceutical

NCT03557658 COMPLETED

Safety and Efficacy of Bexagliflozin in Subjects With Moderate Hepatic Impairment

Theracos

NCT03167411 COMPLETED

Bexagliflozin Drug/Drug Interaction Study With Exenatide Injection

Theracos

NCT01984827 COMPLETED

Effect of Glucose on QTc Interval in Type 1 Diabetes

Richmond Research Institute

NCT03288740 COMPLETED

A Trial to Assess the Pharmacokinetics, Safety and Tolerability of Semaglutide in Healthy Chinese Subjects

Novo Nordisk A/S

NCT04134143 TERMINATED

Multiple Applications of ExpressGraft-C9T1 Skin Tissue as a Treatment for Diabetic Foot Ulcers

Stratatech, a Mallinckrodt Company

NCT02692040 COMPLETED

Study of the Gut Hormone Analogue G3215 in Adult Subjects

Imperial College London

NCT02773381 COMPLETED

A Trial Investigating the Effect of Oral Semaglutide Compared With Placebo on Postprandial Glucose and Triglyceride Metabolism, Energy Intake, Appetite Sensations and Gastric Emptying in Subjects With Type 2 Diabetes

Novo Nordisk A/S

NCT02565862 COMPLETED

A Drug-drug Interaction Study Between Daclatasvir and Metformin

Radboud University Medical Center

NCT03907202 TERMINATED

A Clinical Study to Evaluate the Safety, Tolerability, PK, PD, and Efficacy of KBP-089 in Patients With T2DM

KeyBioscience AG

NCT02634528 COMPLETED

Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics (PD) of Julphar Insulin N and Huminsulin® Basal

Julphar Gulf Pharmaceutical Industries

NCT03027960 COMPLETED

Empagliflozin in Heart Failure: Diuretic and Cardio-Renal Effects

Yale University

NCT02650206 COMPLETED

Effect of Liraglutide (Victoza) on Inflammation in Human Adipose Tissue and Blood

Stanford University

NCT03424044 COMPLETED

Three Way Crossover Closed Loop Study With Xeris Glucagon

Oregon Health and Science University

NCT03944200 COMPLETED

A Study to Investigate the Bioequivalence Test of DA-1229_01(A) at Fed State

Dong-A ST Co., Ltd.

NCT03939143 COMPLETED

A Study to Investigate the Bioequivalence Test of DA-1229_01(A) at Fasting State

Dong-A ST Co., Ltd.

NCT03135015 COMPLETED

Acute Effect of HP-211 (Axulin) on Blood Glucose and Serum Insulin Responses in Healthy Lean and Overweight Humans

Housey Healthcare ULC

NCT03234751 COMPLETED

Effect of Nesiritide Infusion on Insulin Sensitivity in Healthy Obese Insulin Resistant Subjects

AdventHealth Translational Research Institute

NCT04235439 COMPLETED

PK/PD Biosimilarity Study of Gan & Lee Insulin Lispro Injection vs. EU and US Humalog® in Healthy Males

Gan and Lee Pharmaceuticals, USA

NCT03609294 COMPLETED

A Clinical Trial to Evaluate the Pharmacokinetics and Safety/Tolerability of Fimasartan and Linagliptin in Healthy Volunteers

Boryung Pharmaceutical Co., Ltd

NCT03666923 COMPLETED

A Study to Evaluate the Safety of THR-687 in Subjects With Diabetic Macular Edema (DME)

ThromboGenics

NCT03973515 COMPLETED

Clinical Trial for the Investigational Drug (PB-201) in Subjects With Type 2 Diabetes Mellitus

PegBio Co., Ltd.

NCT02935712 COMPLETED

Assessment of the Safety, Tolerability and Pharmacodynamics After Administration of One Dose of AZD8601 to Male Patients With Type II Diabetes Mellitus (T2DM)

AstraZeneca

NCT03292185 COMPLETED

A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese Subjects

Novo Nordisk A/S

NCT04156685 COMPLETED

Pharmacokinetics, Safety and Tolerability of CKD-387 10/500mg BE Phase1

Chong Kun Dang Pharmaceutical

NCT02657876 COMPLETED

ExpressGraft-C9T1 Skin Tissue as a Treatment of Diabetic Foot Ulcers

Stratatech, a Mallinckrodt Company

NCT03462589 COMPLETED

Single Ascending Oral Doses of SY-008 in Healthy Subjects

Suzhou Yabao Pharmaceutical R&D Co., Ltd.

NCT04119947 COMPLETED

Single Ascending Oral Doses of SY-009 in Healthy Subjects

Suzhou Yabao Pharmaceutical R&D Co., Ltd.

NCT02706977 COMPLETED

The Effect of Dopamine on Diabetic Retinopathy

Emory University

NCT02184455 COMPLETED

Feasibility Study of DermGEN for Diabetic Foot Ulcer Treatment

Dr. Paul F. Gratzer

NCT02971202 COMPLETED

Contribution of Hyperinsulinemia vs. Hyperglycemia to Insulin Resistance in Type 1 Diabetes and Maturity Onset Diabetes of the Young, Type 2 (MODY2)

Vanderbilt University

NCT03407599 COMPLETED

A Trial Comparing the Pharmacokinetic Properties of Fast-acting Insulin Aspart Between Children, Adolescents and Adults With Type 1 Diabetes

Novo Nordisk A/S

NCT03466567 COMPLETED

A Trial Investigating the Effect of Probenecid and Ciclosporin on the Concentrations of SNAC in Healthy Subjects

Novo Nordisk A/S

NCT03511898 COMPLETED

A Study to Evaluate the Safety of THR-149 in Subjects With Diabetic Macular Edema (DME)

ThromboGenics

NCT02933853 COMPLETED

A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Faster-acting Insulin Aspart in Subjects With Type 2 Diabetes Mellitus

Novo Nordisk A/S

NCT02536859 COMPLETED

Comparing Pharmacodynamic and Pharmacokinetic Properties of Insulin Degludec and Insulin Glargine 300 U/mL at Steady-state Conditions in Subjects With Type 1 Diabetes Mellitus

Novo Nordisk A/S

NCT02877355 COMPLETED

Investigation of the Effect of Upper Gastrointestinal Disease on the Pharmacokinetics of Oral Semaglutide in Subjects With Type 2 Diabetes.

Novo Nordisk A/S

NCT03766724 COMPLETED

Pharmacokinetic and Pharmacodynamic Drug-Drug Interaction of Evogliptin and Empagliflozin or Dapagliflozin in Healthy Male Adults

Dong-A ST Co., Ltd.

NCT03895229 COMPLETED

The Effect of Morning Versus Evening Administration on The Pharmacokinetics and Pharmacodynamics of Empagliflozin

Ain Shams University

NCT03690778 COMPLETED

The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers.

Jeil Pharmaceutical Co., Ltd.

NCT03215498 COMPLETED

A Research Study of How Faster-acting Insulin Aspart Moves Into, Through, and Out of the Body and How it Works in the Body When Given Through an Insulin Pump to People With Type 1 Diabetes

Novo Nordisk A/S

NCT03063515 COMPLETED

AchE Inhibitor and Insulin

University of Miami

NCT03657537 COMPLETED

Effects of Ketone Bodies on Cognition in Type 2 Diabetes

Bispebjerg Hospital

NCT02620774 COMPLETED

Tissue Penetration of Ceftolozane/Tazobactam in Diabetic Patients With Lower Limb Infections

Hartford Hospital

NCT02620787 COMPLETED

Tedizolid Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo Microdialysis

Hartford Hospital

NCT02568280 COMPLETED

Investigating the Postprandial Glucose Metabolism After Treatment With Faster-acting Insulin Aspart in Subjects With Type 1 Diabetes

Novo Nordisk A/S

NCT03616392 COMPLETED

Clinical Trial to Evaluate the Drug Drug Interaction of CKD-501 and D308

Chong Kun Dang Pharmaceutical

NCT02231658 TERMINATED

Effects of Victoza® Versus Lyxumia® on Gastroesophageal Reflux, Gastric Emptying and Gastric Acid Secretion

Profil Institut für Stoffwechselforschung GmbH

NCT03033433 COMPLETED

DCB-DM101 in Healthy Volunteers and for Type 2 Diabetes Mellitus Patients

VitNovo, Inc.

NCT03444467 COMPLETED

First Research Study to Compare a Possible New Medicine NNC9204-1513 to the Medicine Glucagon, in Healthy People.

Novo Nordisk A/S

NCT03651466 COMPLETED

Safety and Tolerability of GX-G6 in Healthy Male Subjects

Genexine, Inc.

NCT02460354 TERMINATED

Metformin and Congenital Nephrogenic Diabetes Insipidus

Emory University

NCT03009513 COMPLETED

Teneligliptin-Glimepiride DDI Study

Handok Inc.

NCT03072407 COMPLETED

MAD Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PB-119 to Subjects With T2DM

PegBio Co., Ltd.

NCT02982798 COMPLETED

The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers

Jeil Pharmaceutical Co., Ltd.

NCT02449187 COMPLETED

Investigate the Effect of Food on the Pharmacokinetics of JLP-1310 in Healthy Male Volunteers

Jeil Pharmaceutical Co., Ltd.

NCT03367390 COMPLETED

A Study of an Automated Insulin Delivery System in Participants With Type 1 Diabetes Mellitus (T1DM)

Eli Lilly and Company

NCT02938572 COMPLETED

A Randomised Proof-of-Principle Trial Investigating Pharmacodynamics, Pharmacokinetics, and Safety of NNC0143-0406 in Subjects With Type 1 Diabetes Mellitus

Novo Nordisk A/S

NCT02627287 COMPLETED

A Comparative Trial Focusing on Injections With the Medical Device DV3316 Pen-injector Versus FlexPen®

Novo Nordisk A/S

NCT03010475 COMPLETED

A Trial Investigating the Effect of Oral Semaglutide on the Pharmacokinetics of Furosemide and Rosuvastatin in Healthy Subjects

Novo Nordisk A/S

NCT02920385 COMPLETED

A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Levothyroxine and the Influence of Co-administered Tablets on the Pharmacokinetics of Semaglutide Administered Orally in Healthy Subjects.

Novo Nordisk A/S

NCT03179332 COMPLETED

A Trial to Evaluate the Pharmacokinetic and Pharmacodynamic Properties of BioChaperone® Insulin Lispro, Fiasp® and NovoRapid® Delivered by an Insulin Pump

Adocia

NCT02612844 COMPLETED

A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0143-0406 A 0.6 mmol/L in Subjects With Type 1 Diabetes

Novo Nordisk A/S

NCT03203811 COMPLETED

A Phase 1, Study to Evaluate HTI-2088 Tablet

Hengrui Therapeutics, Inc.

NCT02302443 COMPLETED

A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12470

Hanmi Pharmaceutical Company Limited

NCT02954822 COMPLETED

Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of Evogliptin 5mg and Glimepiride 4mg

Dong-A ST Co., Ltd.

NCT02685774 COMPLETED

A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/500mg in Healthy Male Volunteers

Chong Kun Dang Pharmaceutical

NCT02827890 COMPLETED

CKD-396 Drug-drug Interaction Study(B) (CKD-396 DDI(B) P1)

Chong Kun Dang Pharmaceutical

NCT02594033 COMPLETED

A Trial to Investigate Different Needle Features Assessed by Comparing Insulin Aspart Pharmacokinetic Profiles

Novo Nordisk A/S

NCT02845219 COMPLETED

A Trial Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Ethinylestradiol and Levonorgestrel in an Oral Contraceptive Combination Drug in Healthy Postmenopausal Females

Novo Nordisk A/S

NCT02344992 COMPLETED

Blood Glucose Control With BioChaperone Insulin Lispro Compared to Insulin Lispro (Humalog®) After Ingestion of a Standardized Meal

Adocia

NCT03059719 COMPLETED

Clinical Trial for PB-119 in Subjects With Type 2 Diabetes Mellitus

PegBio Co., Ltd.

NCT03059056 COMPLETED

Pharmacokinetic Evaluation of Empagliflozin

British University In Egypt

NCT02715193 COMPLETED

Single-dose Study to Evaluate Safety, Tolerability, and Pharmacodynamics of REMD-477 in Subjects With Type 1 Diabetes Mellitus

REMD Biotherapeutics, Inc.

NCT02557620 COMPLETED

Comparing Semaglutide Administered Subcutaneously Once Daily to Semaglutide Administered Subcutaneously Once Weekly

Novo Nordisk A/S

NCT02877771 COMPLETED

Tandem Predictive Low Glucose Suspend Inpatient Feasibility Study

Tandem Diabetes Care, Inc.

NCT02631928 COMPLETED

Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics (PD) of Julphar Insulin 30/70 and Huminsulin® Profil III

Julphar Gulf Pharmaceutical Industries

NCT02479022 COMPLETED

A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Insulin 320 in Healthy Subjects

Novo Nordisk A/S

NCT02824874 COMPLETED

CKD-396 Drug-drug Interaction Study(A) (CKD-396 DDI(A) P1)

Chong Kun Dang Pharmaceutical

NCT02656212 COMPLETED

Early Phase Pre-Clinical and Initial Clinical Research on Epicatechin (Part 2)

Veterans Medical Research Foundation

NCT02740829 COMPLETED

Assessment of Intranasal Glucagon on Endogenous Glucose Production

University Health Network, Toronto

NCT02648854 COMPLETED

Investigate the Effect of Food on the Pharmacokinetic Characteristics of CKD-395 in Healthy Male Volunteers

Chong Kun Dang Pharmaceutical

NCT02627027 COMPLETED

A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/750 mg in Healthy Male Volunteers

Chong Kun Dang Pharmaceutical

NCT02565368 COMPLETED

A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.5/1000 mg in Healthy Male Volunteers

Chong Kun Dang Pharmaceutical

NCT04416269 ACTIVE NOT RECRUITING

Oral Anti Diabetic Agents in the Hospital

Emory University

NCT06851962 ACTIVE NOT RECRUITING

Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes.

Fundación para la Investigación del Hospital Clínico de Valencia

NCT06813014 NOT YET RECRUITING

Pharmacogenetics of Response to Sitagliptin (PRS)

University of Maryland, Baltimore

NCT05591339 ACTIVE NOT RECRUITING

Diabetes Diagnosis, Management, Prevention and Education in Guinea-Bissau

Bandim Health Project

NCT07401992 RECRUITING

Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis

Hospital Universitario Dr. Jose E. Gonzalez

NCT05051436 RECRUITING

The Effects of Mirabegron and Tadalafil on Glucose Tolerance in Prediabetics

Philip Kern

NCT05426525 ACTIVE NOT RECRUITING

Use of Empagliflozin to Treat Prediabetes

Oregon State University

NCT05164263 RECRUITING

Real World Safety & Efficacy Experience of Empagliflozin With or Without Metformin in T2DM Patients - EASE Study

Getz Pharma

NCT06132477 RECRUITING

Impact GLP-1 Agonists Following Bariatric

University of Missouri-Columbia

NCT04323189 ACTIVE NOT RECRUITING

Effects of Sitagliptin in Individuals With Genetically Decreased DPP4

University of Pennsylvania

NCT03520660 ACTIVE NOT RECRUITING

People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NCT03570632 ACTIVE NOT RECRUITING

Metformin for Preeclampsia Prevention in Pregnant Women With Type 1 Diabetes Mellitus

Maisa N. Feghali, MD

NCT05482789 RECRUITING

Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes

Maisa N. Feghali, MD

NCT07323381 NOT YET RECRUITING

Effects of Henagliflozin Proline and Metformin XR on Body Composition in Geriatric Patients With Newly Diagnosed T2DM

Bin Lu

NCT05579626 ENROLLING BY INVITATION

Comparison of Low-Intensity Statin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus (PROVE-DM)

Seung-Whan Lee, M.D., Ph.D.

NCT06445946 RECRUITING

DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes

Ohio State University

NCT05749874 ACTIVE NOT RECRUITING

Effects of Berberine on Preventing Cardiovascular Disease and Diabetes Mellitus

China National Center for Cardiovascular Diseases

NCT05702931 RECRUITING

Semaglutide Treatment for Hyperglycaemia After Renal Transplantation

Rigshospitalet, Denmark

NCT07228195 NOT YET RECRUITING

SGLT2i Therapy in Islet Transplantation (SIT)

University of Minnesota

NCT07274644 ENROLLING BY INVITATION

Effects of iGlarLixi Versus iGlar on Liver Fat Content in Patients With Type 2 Diabetes Mellitus Combined With Metabolic Dysfunction-associated Steatotic Liver Disease

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

NCT06314061 RECRUITING

The Effect of Continuous Glucose Monitoring in Surgical Patients With Diabetes.

Christian S. Meyhoff

NCT07254572 RECRUITING

Anti-atherosclerotic Efficacy of Selected Antidiabetic Drugs in Patients With Coronary Artery Disease and Pre-diabetes

National Institute of Cardiology, Warsaw, Poland

NCT05454176 RECRUITING

Diabetes in African Youth

University of Minnesota

NCT05390892 RECRUITING

PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes

Brigham and Women's Hospital

NCT03527537 RECRUITING

Gestational Diabetes and Pharmacotherapy (GAP)

Medical College of Wisconsin

NCT07224893 NOT YET RECRUITING

Once-Daily vs Twice-Daily Insulin Glargine in Pregestational Diabetes Management

Eastern Virginia Medical School

NCT03575000 NOT YET RECRUITING

Bromocriptine for Patients With Schizophrenia and Prediabetes

VA Pittsburgh Healthcare System

NCT07117240 ENROLLING BY INVITATION

Evaluation of the Efficacy and Safety of GLP-1 Receptor Agonist Therapy In Steroid-Induced Diabetes

Medical University of Warsaw

NCT07121088 NOT YET RECRUITING

Traditional Chinese Medicine Intervention for Ischemic Cerebrovascular Disease and Diabetes Mellitus: An Efficacy Comparative Study

Guangzhou University of Traditional Chinese Medicine

NCT03938389 ACTIVE NOT RECRUITING

The Renin-Angiotensin-Aldosterone System in Adiposity, Blood Pressure and Glucose in African Americans

Ohio State University

NCT07096908 NOT YET RECRUITING

Tirzepatide Use in People With Obesity and Type 1 Diabetes

Dasman Diabetes Institute

NCT05593653 RECRUITING

Efficacy of Suvorexant in the Treatment of Insomnia in Midlife Women With Pre-Diabetes

Brigham and Women's Hospital

NCT06054035 RECRUITING

SGLT2 Inhibition in Addition to Lifestyle Intervention and Risk for Complications in Subtypes of Patients With Prediabetes

University Hospital Tuebingen

NCT04297592 ENROLLING BY INVITATION

Antibiotic Prophylaxis in High-Risk Arthroplasty Patients

Mayo Clinic

NCT07017270 NOT YET RECRUITING

Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysis

Unity Health Toronto

NCT06999551 NOT YET RECRUITING

Comparison of the Efficacy and Safety of GLARGEN® Versus NPH Insulin in Diabetic Tunisian Patients.

Les Laboratoires des Médicaments Stériles

NCT06140537 RECRUITING

Efficacy and Mechanisms of Dapagliflozin in Promoting Kidney Function and Cardiovascular Health in Kidney Transplant Recipients

University of Colorado, Denver

NCT06959784 ENROLLING BY INVITATION

Assessing Incretin Therapy for Cardiovascular Risk Reduction and Diabetes Remission( ITCRDR Study)

China-Japan Friendship Hospital

NCT06767774 RECRUITING

Comparison of Pitavastatin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus

Korea University Anam Hospital

NCT04407650 ACTIVE NOT RECRUITING

Ursodeoxycholic Acid vs Metformin in Gestational Diabetes Mellitus

King's College London

NCT06903546 RECRUITING

The Effect of Propolis Administration on Cholesterol Level in Diabetic Type 2 Patients

Indonesia University

NCT06875193 RECRUITING

DM Treatment to Evaluate the Efficacy and Safety of Dapagliflozin or Pioglitazone in Patients with Type 2 Diabetes

Dong Wha Pharmaceutical Co. Ltd.

NCT04873050 RECRUITING

Treatment to Regress to Normoglycemia in Women with a Recent History of GDM

Woman's

NCT06862739 NOT YET RECRUITING

Glycemic Control with Triple Pathway Approach Through Empagliflozin, Linagliptin and Metformin Combination

Nabiqasim Industries (Pvt) Ltd

NCT06846411 RECRUITING

The EMPA-FIT Study

Seoul National University Bundang Hospital

NCT03059069 RECRUITING

The Effect of Gliatamin (Chonline Alphoscerate) on Depressive Mood in Type 2 Diabetes Patients

Yonsei University

NCT05659147 ENROLLING BY INVITATION

Imaging Biomarkers of Pancreatic Function and Disease

Children's Hospital Medical Center, Cincinnati

NCT06699810 RECRUITING

Modeling Ketosis-Prone Diabetes Remission Via Diverse Mechanisms of Glucotoxicity

Emory University

NCT06781775 RECRUITING

GDM: Insulin with or Without Metformin?

University of Virginia

NCT05119179 RECRUITING

Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes

The University of Texas Health Science Center, Houston

NCT06427889 RECRUITING

Treatment Effects of Two Pharmaceutical Skin Care Creams for Xerotic Feet Among Persons with Diabetes

Malmö University

NCT06709313 ACTIVE NOT RECRUITING

Effect of Chromium on Blood Sugar After Sacroiliac Joint Injection

Fayoum University

NCT05708859 RECRUITING

Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT

Matthew J. Budoff

NCT06191094 ENROLLING BY INVITATION

Pre-operative Vabysmo in Patients With Non-clearing Vitreous Hemorrhage Secondary to Proliferative Diabetic Retinopathy

University of Colorado, Denver

NCT06449235 NOT YET RECRUITING

Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh

Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders

NCT06449833 RECRUITING

Effect of Henagliflozein on Hepatic Fat Content in Patients With T2DM and NAFLD

Zhujiang Hospital

NCT06448130 NOT YET RECRUITING

Henagliflozin's Impact on Prediabetes Remission

Shandong Provincial Hospital

NCT06442280 NOT YET RECRUITING

SGLT-2 Inhibitor and High-Dose Furosemide Plus Small-Volume Hypertonic Saline Solution in Acute HF

University of Palermo

NCT06439758 NOT YET RECRUITING

Effects of First-Line Oral Hypoglycemics in Bone Markers of Treatment Naïve Saudi Adults With Type 2 Diabetes

King Saud University

NCT03851627 RECRUITING

Effects of Testosterone Undecanoate vs Placebo on Intrahepatic Fat Content in Overweight/Obese Men With T2DM or Prediabetes and Hypogonadism

Alexandra Kautzky-Willer

NCT06263348 RECRUITING

A Post-Marketing Safety Study of Dorzagliatin in Patients With Type 2 Diabetes

Hua Medicine Limited

NCT06216340 NOT YET RECRUITING

Efficacy of Henagliflozin for Weight Loss in Obesity Without Diabetes

The First People's Hospital of Changzhou

NCT05727579 NOT YET RECRUITING

DiEtary Sodium Intake Effects on Ertugliflozin-induced Changes in GFR, reNal Oxygenation and Systemic Hemodynamics: the DESIGN Study

Amsterdam UMC, location VUmc

NCT04698330 NOT YET RECRUITING

Effects Of Berberine Plus Inulin On Diabetes Care in Patients With LADA

Second Xiangya Hospital of Central South University

NCT04286399 RECRUITING

Asian Diabetes Outcomes Prevention Trial

National Heart Centre Singapore

NCT03514108 COMPLETED

DANHEART (H-HeFT and Met-HeFT)

Henrik Wiggers

NCT06094920 COMPLETED

Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial

University Medical Center Groningen

NCT04954313 COMPLETED

Baseline Oral Health Study: UnCoVer the Connections to General Health

University of North Carolina, Chapel Hill

NCT04897802 COMPLETED

Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

NCT03012529 COMPLETED

Investigation of Rifampin to Reduce Pedal Amputations for Osteomyelitis in Diabetics

VA Office of Research and Development

NCT04952766 COMPLETED

Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults

Centre Hospitalier Régional d'Orléans

NCT02520921 COMPLETED

Aspirin Twice a Day in Patients With Diabetes and Acute Coronary Syndrome

Assistance Publique - Hôpitaux de Paris

NCT06845891 COMPLETED

Clinical Study: Analysis of Glycemic Control and Satisfaction With a Connected Smart Cap in Patients With Type 1 Diabetes Mellitus

Fernando Sebastián Valles

NCT03260881 COMPLETED

Liraglutide Effects on Epicardial Fat Inflammatory Genes

University of Miami

NCT05922033 COMPLETED

Patient Versus Provider-led Titration of Insulin for Glycemic Control in Gestational Diabetes (EMPOWER)

Ohio State University

NCT02713997 COMPLETED

Anti-inflammatory Therapy to Improve Outcomes After TPIAT

University of Minnesota

NCT05786521 COMPLETED

Effect of GLP1 Receptor Agonists on Physical Function, Body Composition, and Markers of Aging in Older Adults

The University of Texas Health Science Center at San Antonio

NCT04523363 WITHDRAWN

Metformin Versus Standard of Care Treatment in Pregnant Women With Prediabetes

Gianna Wilkie

NCT04288778 COMPLETED

A Study to Assess Safety of Canagliflozin and Metformin Hydrochloride Combination Given as a Supplement to Diet and Exercise to Improve Blood Sugar Level in Indian Adult Participants With Diabetes

Johnson & Johnson Private Limited

NCT05743907 COMPLETED

Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing Metformin Monotherapy in Patients with Type 2 Diabetes Who Have Inadequate Glycemic Control

Dong-A ST Co., Ltd.

NCT05677334 COMPLETED

Combination of Henagliflozin and Continuous Subcutaneous Insulin Infusion in T2DM

First Affiliated Hospital of Guangxi Medical University

NCT06721442 COMPLETED

Effect of Dapagliflozin on Electrocardiographic Parameters in Type 2 Diabetes Patients: DAPA - ECG Study

Beneficência Portuguesa de São Paulo

NCT05218915 COMPLETED

Basal Plus GLP1-ra on Glycemic Variability in CKD

Elaine Chow

NCT03029702 COMPLETED

Metabolic Analysis for Treatment Choice in Gestational Diabetes Mellitus

Maisa N. Feghali, MD

NCT06674135 COMPLETED

Evaluating the Impact of Introducing Basaglar, a Long-acting Analog Insulin, on Clinical and Quality of Life Outcomes in Youth with Diabetes in Bangladesh

Life for a Child Program, Diabetes Australia

NCT06046560 COMPLETED

Diabetes Remote Intervention to improVe Use of Evidence-based Medications

Brigham and Women's Hospital

NCT06637384 COMPLETED

Effect of Hyaluronic Acid and Single Dose Corticosteroid Injection to Improve Wound Healing in Controlled Diabetic Patients Post Tooth Extraction.

Rimsha Rasheed

NCT05139472 COMPLETED

Impact of Empagliflozin on Functional Capacity in Heart Failure with Preserved Ejection Fraction

University of Texas Southwestern Medical Center

NCT04743453 COMPLETED

EFFECT OF ADDING DAPAGLIFLOZIN TO ALLOGRAFT DYSFUNCTION OF RENAL TRANSPLANTED PATIENTS.

University of Sao Paulo General Hospital

NCT03036800 COMPLETED

Saxenda in Obesity Services (STRIVE Study)

University of Leicester

NCT06475586 COMPLETED

Effect of Semaglutide on the Psoriatic Lesions in Patients With Type 2 Diabetes Mellitus

University of Banja Luka

NCT04249778 COMPLETED

Dapagliflozin at Discharge on Hospital Heart Failure Readmission

Emory University

NCT03437330 WITHDRAWN

Empagliflozin Effect on Glucose Toxicity

University Hospital Tuebingen

NCT06396819 COMPLETED

Collagen-povidone for Diabetic Seniors' Tenosynovitis

Instituto Mexicano del Seguro Social

NCT06374043 COMPLETED

Decentralized N=1 Study: A Feasible Approach to Evaluate Individual Therapy Response to Dapagliflozin.

University Medical Center Groningen

NCT03029351 TERMINATED

GLP-1 Receptor Agonist Therapy and Albuminuria in Patients With Type 2 Diabetes

University at Buffalo

NCT04902235 COMPLETED

Identification and Clinical Relevance of an Oxytocin Deficient State (CRH Study)

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

NCT03269058 COMPLETED

Evaluate the Effects of Dapagliflozin in Patients With Type 2 Diabetes

Centre Hospitalier Universitaire Dijon

NCT06252051 COMPLETED

Effectiveness of Trivalent Influenza Vaccine (TIV) in Type 2 Diabetes Mellitus (T2DM) Patients With and Without Complications of Chronic Kidney Disease (CKD)

Universitas Padjadjaran

NCT03258723 TERMINATED

Diabetes Prevention With Lifestyle Intervention and Metformin Escalation

Yale University

NCT05396898 COMPLETED

Tacrolimus Formulation and Glucose Metabolism After Kidney Transplantation (TAGLUMET Trial)

University Hospital Tuebingen

NCT04496401 COMPLETED

PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus

Nantes University Hospital

NCT03642184 TERMINATED

Efficacy and Safety of Empagliflozin in NODAT

RenJi Hospital

NCT03829514 COMPLETED

Fenofibrate in Type 2 Diabetes

Medical University of South Carolina

NCT05457933 COMPLETED

Efficacy and Safety of Dapagliflozin for the Hospital Management of Patients With Type 2 Diabetes

Medanta, The Medicity, India

NCT03765359 COMPLETED

Metformin Use to Improve Pregnancy Outcome in Women With Type 1 Diabetes.

Tampere University Hospital

NCT04938388 TERMINATED

Comparison of Oral Semaglutide w/ Placebo- Treatment for Latino Adults w/T2 Diabetes Receiving Enhanced Lifestyle Care

Sansum Diabetes Research Institute

NCT05870358 COMPLETED

Melatonin Supports Non Surgical Periodontal Treatment in Patients With Type 2 Diabetes and Periodontitis

Yağmur Saraç Gül

NCT02621489 COMPLETED

Effects on Re-endothelialisation With Bydureon Treatment in Type 2 Diabetes Subjects

Karolinska Institutet

NCT04080518 COMPLETED

Hepato-renal Regulation of Water Conservation in Heart Failure Patients With SGLT-2 Inhibitor Treatment

National Heart Centre Singapore

NCT05806723 COMPLETED

Effects of High Intensity Statin Therapy on Steroid Hormones and Vitamin D in Type 2 Diabetic Men

Hopital La Rabta

NCT04917692 WITHDRAWN

Empagliflozin in Adolescent Diabetes

Ohio State University

NCT03292315 COMPLETED

Once Weekly GLP-1 in Persons With Spinal Cord Injury

James J. Peters Veterans Affairs Medical Center

NCT03932721 COMPLETED

EXpanded Combination of Evolocumab Plus Empagliflozin on Diabetes: EXCEED-BHS3 Trial

University of Campinas, Brazil

NCT03829046 COMPLETED

The Effects of Evolocumab in Patients With Diabetes and Atherosclerotic Vascular Disease

Robert Rosenson

NCT05479214 COMPLETED

Effect of Adding Metformin to Insulin in Uncontrolled Diabetic Patients During the 3rd Trimester of Pregnancy

Cairo University

NCT05713396 COMPLETED

Diabetic Autonomic Neuropathy and Left Ventricular Function

AHEPA University Hospital

NCT03472846 COMPLETED

MiDeTe - microRNA Levels Under Denosumab and Teriparatide Therapy in Postmenopausal Osteoporosis

Medical University of Vienna

NCT03258281 TERMINATED

Effects of Evolocumab on Platelet Reactivity in Patients With Diabetes Mellitus

Inova Health Care Services

NCT04910178 COMPLETED

Follow-up of NAFLD Patients With MRI-PDFF

Asmaa Abdelfattah Elsayed

NCT03580967 WITHDRAWN

Vortioxetine Monotherapy for Major Depressive Disorder in Type 2 Diabetes

Todd Doyle

NCT03101930 COMPLETED

Cardiovascular Effects of GLP-1 Receptor Activation

Vanderbilt University Medical Center

NCT04724967 COMPLETED

CeraVe Diabetes Mellitus

University of Miami

NCT02462421 TERMINATED

Pharmacogenetics of SGLT2 Inhibitors

University of Maryland, Baltimore

NCT02743598 TERMINATED

Liraglutide for HIV-associated Neurocognitive Disorder

Temple University

NCT03088410 COMPLETED

Study of HIV-Infected and Uninfected Pregnant Woman/Child Dyads in Gaborone, Botswana

Ann & Robert H Lurie Children's Hospital of Chicago

NCT03398356 COMPLETED

Metformin and Its Impact on the Substances Associated With NO Production in Prediabetes Patients.

Wroclaw Medical University

NCT05393843 TERMINATED

Prevention of Maternal and Fetal Metabolic Complications With Diet and Nutraceutical Supplementation in Pregnant Women Affected by Gestational Diabetes: a Randomized, Double-blind Placebo Controlled Trial.

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

NCT03597035 TERMINATED

Mineralocorticoid Receptor Antagonism Clinical Evaluation in Atherosclerosis Add-On

University Hospitals Cleveland Medical Center

NCT04697485 WITHDRAWN

Polydiuretic Therapy for Heart Failure With Preserved Ejection Fraction and Diabetes Mellitus

Northwestern University

NCT03406000 COMPLETED

Phase 4 Study to Evaluate Treatment Optimization With Once-daily Insulin Glargine 300 U/mL

Sanofi

NCT03007329 COMPLETED

Effects of Combined Dapagliflozin and Exenatide Versus Dapagliflozin and Placebo on Ectopic Lipids in Patients With Uncontrolled Type 2 Diabetes Mellitus.

Medical University of Vienna

NCT02808351 COMPLETED

Berberine Prevent Contrast-induced Nephropathy in Patients With Diabetes

Nanjing First Hospital, Nanjing Medical University

NCT02539160 COMPLETED

Impact of Chronic Kidney Disease on the Effects of Ticagrelor in Patients With Diabetes and Coronary Artery Disease

University of Florida

NCT03441750 COMPLETED

Efficacy of Metformin in Preventing Diabetes in China

Chinese Association of Geriatric Research

NCT02571608 WITHDRAWN

Continuation of Metformin to Improve And Keep Peri-operative Glycemic Control

McMaster University

NCT04157738 COMPLETED

A Study of Rapid-Acting Mealtime Insulin in Children and Adolescents With Newly Diagnosed Type 1 Diabetes Mellitus

Emory University

NCT04497792 COMPLETED

Safety and Efficacy of Empagliflozin for Patients With Diabetes Mellitus and Planned Percutaneous Coronary Interventions

Research Institute for Complex Problems of Cardiovascular Diseases, Russia

NCT03670043 COMPLETED

Tolerance & Responsiveness Improvement for Metformin (TRIM)

West Side Institute for Science and Education

NCT03893526 COMPLETED

Effect of Neprilysin on Glucagon-Like Peptide-1 in Patients With Type 2 Diabetes

University of Copenhagen

NCT03910361 COMPLETED

Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver Diseases

Dong-A ST Co., Ltd.

NCT04824586 COMPLETED

Intraoperative Insulin Administration at Cardiac Surgery for Diabetic Patients

The Hashemite University

NCT04409587 COMPLETED

Basal Insulin Glycemic ControL With DEglugec vs Aspart Via Pump

Mountain Diabetes and Endocrine Center

NCT03646916 WITHDRAWN

Intraoperative Dexamethasone and Its Effect on Hyperglycemia

Ascension Health

NCT02655770 COMPLETED

Effect of Liraglutide on Diastolic Dysfunction on Cardiac MRI in Type 2 Diabetes Patients

Rigshospitalet, Denmark

NCT03784703 COMPLETED

Type 2 Diabetic Patients Maintained on Statin Therapy

Damanhour University

NCT04123587 COMPLETED

Genetic Variants Replication Study Associated With Dependence on Sulfonylurea in Participants With Type 2 Diabetes

Seoul National University Hospital

NCT04665284 COMPLETED

Safety And Efficacy Of Empagliflozin In Pakistani Muslim Population With Type Ii Diabetes Mellitus

Getz Pharma

NCT04473274 COMPLETED

GlitazOne Treatment for Coronavirus HypoxiA, a Safety and Tolerability Open Label With Matching Cohort Pilot Study

Samaritan Health Services

NCT02935855 COMPLETED

ORal anticoaGulants in diAbetic and Nondiabetic Patients With nOn-valvular Atrial fibrillatioN (ORGANON)

University of Pavia

NCT03006471 COMPLETED

Effect of Dapagliflozin on Blood Pressure Variability in Prediabetes and Prehypertension

University of Guadalajara

NCT02802514 TERMINATED

A Study Comparing the Effect of Albiglutide With Exenatide on Regional Brain Activity Related to Nausea in Healthy Subjects

GlaxoSmithKline

NCT02700334 COMPLETED

Effect of Dapagliflozin on Insulin Secretion and Insulin Sensitivity in Patients With Prediabetes

University of Guadalajara

NCT03526536 TERMINATED

Pilot: Insulin Sensitivity/Management in Hyperglycemic Patients in Perioperative Period ESRD/Non-ESRD

State University of New York - Downstate Medical Center

NCT02973477 COMPLETED

Dapagliflozin and Measures of Cardiovascular Autonomic Function in Patients With Type 2 Diabetes (T2D)

University of Michigan

NCT03485092 COMPLETED

Studies of Empagliflozin and Its Cardiovascular, Renal and Metabolic Effects

NHS Greater Glasgow and Clyde

NCT04549415 COMPLETED

The Influence of Metformin on Chronic Heart Failure Clinical Course in Patients With Prediabetes

National Center of Cardiology and Internal Medicine named after academician M.Mirrakhimov

NCT03511521 TERMINATED

Use of NPH Versus Basal Bolus Insulin for Steroid Induced Hyperglycemia

Northwestern University

NCT03978884 WITHDRAWN

Phase 4 Study of the Efficacy of Losartan Based Therapy in Hypertensives With and Without Diabetes

The University of The West Indies

NCT03108521 COMPLETED

SNP Study of DPP-4 and GLP-1R in Chinese People (Including Diabetes Patients)

Sichuan Provincial People's Hospital

NCT03027934 WITHDRAWN

A Single Center Study to Evaluate Ticagrelor Mechanism of Action in Inhibiting Juvenile Platelet ADP Response

CirQuest Labs, LLC

NCT02730377 COMPLETED

Efficacy in Controlling Glycaemia With Victoza® (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 Diabetes

Novo Nordisk A/S

NCT03349840 TERMINATED

Randomised Open Label Study of Insulin Degludec Versus Insulin Glargine U100 in Ramadan

Weill Cornell Medical College in Qatar

NCT03928340 COMPLETED

Effect of Adding Metformin to Insulin Therapy on Pregnancy Outcomes in Women With Uncontrolled Type I Diabetes.

Kasr El Aini Hospital

NCT04377399 COMPLETED

High vs Low Dose Vitamin D in Patients With Diabetic Peripheral Neuropathy

Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health

NCT03387683 COMPLETED

A Clinical Study to Investigate the Effects of Dapagliflozin on Heart Work, Heart Nutrient Uptake, and Heart Muscle Efficiency in Type 2 Diabetes Patients

AstraZeneca

NCT02481479 COMPLETED

Saxagliptin and Cardiac Structure and Function

Unity Health Toronto

NCT03191201 TERMINATED

A Double Blind Randomised Placebo-controlled Trial to Assess the Role of Iron Repletion in Glucose Homeostasis.

Prof Gérard WAEBER

NCT02508844 COMPLETED

Effect of Probiotics (Vivomixx®) on Weight, Microbiota and Glucose Tolerance in Obese Pregnant Women and Their Newborn

Hvidovre University Hospital

NCT03977116 COMPLETED

Sodium-glucose Co-transporter 2 Inhibitors Effects in Failing Heart Patients

University of Campania Luigi Vanvitelli

NCT02548650 COMPLETED

Vorapaxar as an Add-On Antiplatelet Therapy in Patients With and Without Diabetes Mellitus

University of Florida

NCT02887677 TERMINATED

Effects of Dapagliflozin on Central Hemodynamics and Urine Albumin Excretion in Patients With Type 2 Diabetes.

Hellenic Society for Medical Education

NCT04143321 COMPLETED

Antiischemic Effects of Empagliflozin in Diabetic Patients With Refractory Angina

Isfahan University of Medical Sciences

NCT03813316 WITHDRAWN

Approaches To Therapy Escalation In T2D

LMC Diabetes & Endocrinology Ltd.

NCT02910089 COMPLETED

ENhancing Outcomes Through Goal Assessment and Generating Engagement in Diabetes Mellitus

AstraZeneca

NCT02987751 COMPLETED

A Study on Comparison of Glargine Plus Glulisine With Premixed Insulin in Type 2 Diabetes Patients

India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals

NCT02488057 COMPLETED

Improving Beta Cell Function in Mexican American Women With Prediabetes

Ohio State University

NCT02330406 COMPLETED

Randomized Evaluation of Anagliptin Versus Sitagliptin On Low-density lipoproteiN Cholesterol in Diabetes Trial

Institute for Clinical Effectiveness, Japan

NCT03208465 COMPLETED

Empagliflozin Versus Sitagliptin Therapy for Improvement of Myocardial Perfusion Reserve in Diabetic Patients With Coronary Artery Disease

CHEOL WHAN LEE, M.D., Ph.D

NCT02302508 WITHDRAWN

Pharmacokinetics of Antiplatelet Drugs in Diabetic pAtients

Centre hospitalier de l'Université de Montréal (CHUM)

NCT03361709 WITHDRAWN

Effect of Intracameral Dexamethasone After Phacoemulsification in Diabetics on Corneal Endothelial Cell Density

Cairo University

NCT03039075 COMPLETED

Metformin SR Tablet (DuLeNing) and Glucophage in Patients With Type 2 Diabetes

Chongqing Medical University

NCT03717688 COMPLETED

The Effects of Neprilysin on Glucagon-like Peptide-1

Nicolai Jacob Wewer Albrechtsen

NCT02582242 COMPLETED

Comparing Efficacy and Safety of Thrice Daily Versus Twice Daily NovoMix® 30 (Biphasic Insulin Aspart 30) in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin

Novo Nordisk A/S

NCT03530930 COMPLETED

Comarum Palustre in Knee Osteoarthritis and Diabetes

Federal State Budgetary Scientific Institution, Research Institute of Fundamental and Clinical Immunology

NCT03278483 COMPLETED

Efficacy, Security, Adherence, Tolerability and Cost Effectiveness of Latent TB Treatment in Patients With TB/DM2 (TBL)

Instituto Nacional de Salud Publica, Mexico

NCT02798757 COMPLETED

Evaluation of the Tubular Effects of Dapagliflozin Using 1HNMR Spectroscopy

University of Ioannina

NCT02226510 COMPLETED

MetfoRmin and Its Effects on Left Ventricular Hypertrophy in Normotensive Patients With Coronary Artery Disease

University of Dundee

NCT02728453 TERMINATED

SGLT2 Inhibition and Left Ventricular Mass

Hannover Medical School

NCT03157414 COMPLETED

Empagliflozin in Renal Transplant Recipients

Oslo University Hospital

NCT02465515 COMPLETED

Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes Mellitus

GlaxoSmithKline

NCT03387826 COMPLETED

Low Dose Ticagrelor Versus Low Dose Prasugrel in Patients With Prior Myocardial Infarction

Attikon Hospital

NCT02373865 TERMINATED

Risk of Nocturnal Hypoglycemia and Arrhythmias With Sitagliptin Versus Glimepiride in Patients With Type 2 Diabetes

GWT-TUD GmbH

NCT03011177 COMPLETED

Teneligliptin Versus Linagliptin in Diabetes Mellitus Type Two Patients

Handok Inc.

NCT02617693 COMPLETED

Development of Pre-pregnancy Intervention to Reduce the Risk of Diabetes and Prediabetes

Novo Nordisk A/S

NCT03319784 WITHDRAWN

Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients

Milton S. Hershey Medical Center

NCT02453685 COMPLETED

A Study to Compare Insulin Intensification of Biphasic Insulin Aspart 30 and Insulin Analogues (Insulin Glargine and Insulin Aspart) in Insulin naïve Type 2 Diabetic Patients

Novo Nordisk A/S

NCT03824002 COMPLETED

Dulaglutide in Diabetic Patients, Relationship Between Arterial Stiffness, Endothelial Function, Clinical and Laboratory Variables

University of Palermo

NCT02499185 TERMINATED

Study Evaluating Novel Biomarkers of AKI (Acute Kidney Injury) in Post-operative Patients

Universitair Ziekenhuis Brussel

NCT02985242 TERMINATED

Empagliflozin Reduces Progression of Diabetic Retinopathy in Patients With High Risk of Diabetic Macular Edema

Hannover Medical School

NCT02473809 COMPLETED

The Effect of Liraglutide on Bone Turnover, Bone Mass and Bone Cell Function

University of Aarhus

NCT02610088 COMPLETED

Effect of Dapagliflozin on Vascular Functions in Patients With Type 2 Diabetes Compared to Gliclazide

Seoul National University Bundang Hospital

NCT02397421 COMPLETED

Safety and Effectiveness of SGLT-2 Inhibitors in Patients With Heart Failure and Diabetes

University of Dundee

NCT02974504 COMPLETED

Phase IV Clinical Trial to Investigate the Effect on Blood Glucose of Evogliptin in Patients With Type 2 Diabetes(EVERGREEN)

Dong-A ST Co., Ltd.

NCT02304081 COMPLETED

Saxagliptin in Combination With Dapagliflozin - Effects on Islet Cell Function

Prof. Dr. Thomas Forst

NCT02809963 COMPLETED

Mineralocorticoid Receptor Antagonists in Type 2 Diabetes

Herlev Hospital

NCT02706119 COMPLETED

Insulin in Total Parenteral Nutrition

Fundación Pública Andaluza Progreso y Salud

NCT03078725 WITHDRAWN

Failure Rate of GLyburide And Metformin Among Gestational Diabetics

The University of Texas Health Science Center, Houston

NCT02312427 COMPLETED

DPP-4 Inhibitor and Serum BNP Level of Diabetic Patients With Congestive Heart Failure

Mitsui Memorial Hospital

NCT02660047 COMPLETED

Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients of South Asian Descent

Leiden University Medical Center

NCT02768220 WITHDRAWN

The Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Advanced Glycation End Products

Northwell Health

NCT02249897 COMPLETED

PRELIMINARY EVALUATION OF PHARMACOLOGICAL LOWERING OF AGEs

University of Chile

NCT02789319 COMPLETED

DTS Blood Glucose Monitor System Surveillance Program SubStudy 1

Diabetes Technology Society

NCT03190798 WITHDRAWN

Effects of Canagliflozin on Intravascular Volume and Hemodynamics

The University of Texas Health Science Center at San Antonio

NCT02624817 COMPLETED

Long-Term Sulfonylurea Response in KCNJ11 Neonatal Diabetes

Haukeland University Hospital

NCT03112382 COMPLETED

Effect of SLC30A8 rs13266634 Genetic Polymorphism on Zinc Supplementation and Glycemic Control in Egyptian Patients With Type 2 Diabetes Mellitus

Cairo University

NCT02663713 COMPLETED

A Randomized, Pharmacodynamic Comparison of Low Dose Ticagrelor to Clopidogrel in Patients With Prior Myocardial Infarction

University of Patras

NCT02429258 COMPLETED

Effect of Dapagliflozin on 24-hour Blood Glucose in T2DM Patients Inadequately Controlled With Either Metformin Or Insulin

AstraZeneca

NCT02767596 TERMINATED

Evaluation of Lixisenatide Efficacy in Diabetes Mellitus Type 2 With Failure of Other GLP-1 Analog

Laniado Hospital

NCT02597309 WITHDRAWN

The Effect of add-on Canagliflozin in Patients With Type 2 Diabetes Treated With U-500 Insulin

Joslin Diabetes Center

NCT02255682 COMPLETED

Living With Statins - The Impact of Cholesterol Lowering Drugs on Health, Lifestyle and Well-being

University of Copenhagen

NCT02429024 COMPLETED

Assessment of SMS and Smartphone Interventions for OneTouch Reveal® Experiences

LifeScan

NCT02081989 WITHDRAWN

Renal Denervation in Diabetes.

Monash University

NCT02719132 WITHDRAWN

Effect of DapagliFLOzin on Quality of Life in Patients With Type 2 Diabetes in a Real Clinical PrActice

AstraZeneca

NCT02272296 COMPLETED

Reliability of Insulin by Jet Injection

Radboud University Medical Center

Data: ClinicalTrials.gov